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1. Abstract
Healthcare outcomes research based on administrative data is frequently 
hindered by two important challenges: (1) accurate adjustment for disease burden and 
(2) effective management of missing data in key variables. Standard approaches exist 
for both problems, but these may contribute to biased results. For example, several well-
established summary measures are used to adjust for disease burden, often without 
consideration for whether other methods could perform this task more accurately.  
Similarly, observations with missing values are often arbitrarily excluded, or the values 
are imputed without regard for the involved assumptions. Despite recent substantial 
gains in computing power, statistical approaches and machine learning methods, no 
comprehensive effort has been made to develop an improved comorbidity index based 
on predictive performance comparisons of competing approaches. Similarly, recently 
developed machine learning approaches have shown promise in addressing missing 
data problems, but these have not been compared with parametric methods via a 
rigorous simulation study using large-dimensional data with the complete range of 
missingness types. This makes it difficult to assess the relative merits of each 
procedure. 
This work accomplished three broad aims:  (1) Improved models for summarizing 





variety of statistical and machine learning methods. (2) A new comorbidity summary 
score for predicting five-year mortality was developed. (3)  A comprehensive comparison 
of machine learning and model-based multiple imputation methods was completed, both 
in simulations and through an application to real data. Several sensitivity analyses were 
also examined for variables with missing not at random (MNAR) missingness.     
  This work successfully demonstrated several new approaches for summarizing 
disease burden. Each of the competing disease burden models in the first aim and the 
summary score from the second aim had superior predictive performance when 
compared to the Elixhauser index, a commonly-used summary measure. This research 
also led to new applications for applying machine learning methods within the multiple 
imputation with chained equations (MICE) framework. Additionally, several MNAR 
sensitivity methods were adapted and applied to demonstrate that unbiased inference 
under MNAR may not be possible in some situations, even when the missingness 







2.  Introduction 
 
2.1 Motivation 
 The motivation for this research came from my work in the Veteran’s Health 
Administration’s (VHA) Health Services Research and Development (HSR&D) Center of 
Innovation (COIN) for Health Equity and Rural Outreach, located in Charleston, South 
Carolina. This group works to reduce disparities in healthcare access and outcomes 
between Veterans due to racial, ethnic, geographic, or gender-based differences. Much 
of this research involves observational studies based on VHA and Medicare 
administrative healthcare datasets, which typically involve millions of patients, each of 
whom may have thousands of observations involving demographic information, 
diagnostic and procedure codes, laboratory results, pharmacy records, text notes, and 
cost data. Most studies are forced to deal with two key challenges:  
 1) Models examining differences between groups must accurately account for each 
patient’s disease burden by summarizing information contained in diagnostic 
codes, for which there are thousands of unique values. 
 2) Many patients are missing data in key variables that are essential for making 
any valid inference concerning disparities, such as the race/ethnicity variable. 






 Standard approaches exist for both problems, but these may risk contributing to 
biased results. For example, investigators often use the Charlson or Elixhauser 
Comorbidity indices [1, 2] to summarize a patient’s disease burden from the information 
collected from thousands of covariates, but they may do this without regard for the 
assumptions and limitations associated with these measures. When dealing with missing 
data, some investigators exclude observations with missing values and only consider 
complete cases, while others impute values using models that are based on missing-at-
random (MAR) assumptions. Either option could lead to bias, particularly since 
missingness patterns for some important variables in VHA data likely violate this crucial 
MAR assumption [3 – 6] . 
 In developing better approaches for these challenges, it was important to 
consider the full range of available methods, and to consider whether approaches that 
combined the strengths of several methods might produce superior results. For example, 
substantial advances in computing power, statistical and machine learning methods 
since the Elixhauser index’s development in 1998 could support the development of an 
improved summary measure, perhaps one based on the combined predictions of several 
methods. Similarly, statistical and machine learning methods each bring different 
strengths to the missing data problem. 
 
2.2 Specific Aims 
2.2.1  Aim 1 
 Using two large Veteran’s Health Administration cohorts involving diabetes and 
traumatic brain injury, develop improved models for summarizing disease burden from 
3 
large-dimension binary diagnostic features data by training and validating models based 
on a wide variety of statistical and machine learning methods for variable selection and 
dimension reduction, including a model based on the pooled predictions of the other 
models. Compare each method’s predictive performance with existing scores using 
AUC, sensitivity, specificity, positive predictive value (PPV), negative predictive value 
(NPV), and net reclassification improvement statistics for events and non-events. Include 
methods from the following broad categories: 
a. Generalized linear model and regularized regression approaches:
(i) Model-Averaged Regression Coefficients (MARC)
(ii) Probability Based Features (PBF).
(iii) Penalized generalized linear model (elastic-net)
b. Machine learning methods:
(i) Association Rules Analysis (unsupervised method)
(ii) Random Forest (supervised method)
c. Bayesian methods (includes machine learning approaches)
(i) Naïve Bayes variable selection (Multi-morbidity Index)
(ii) Bayesian Additive Regression Trees
Compare model performance for several mortality outcomes, by applying several 
methods of establishing baseline comorbidities, and by validating models on both single-
disease populations and combined populations.  
2.2.2 Aim 2:  
Develop a new comorbidity summary score for predicting five-year mortality based on 
variable importance measures from the top-performing models in the first aim. Train and 
validate these models using three large VA cohorts with diabetes (DM), chronic kidney 





performance to the Elixhauser-Quan index using AUC, sensitivity, specificity, Brier 
Index, and net reclassification index statistics. Determine if the new score provides any 
population insights beyond those provided by the existing Elixhauser-Quan index. 
 
2.2.3 Aim 3 
Compare machine learning and model-based multiple imputation methods for dealing 
with missing covariate data under missing at random (MAR) and missing not at random 
(MNAR) scenarios. For MNAR situations, also examine sensitivity analysis approaches 
to determine whether unbiased imputation is possible in typical missing data scenarios 
seen in VA research. Evaluate imputation performance using simulations and by 
application to VA traumatic brain injury data using relative bias, root mean squared error, 
efficiency, and coverage probability statistics.  
 
2.2.4 Aim 4: 
Publish the R and SAS program code used in each aim on GitHub, along with a 
simulated dataset that can be used to demonstrate its function. 
 
2.3 Background 
2.3.1 Diagnostic code system 
 In administrative healthcare data, comorbidity information can be found in 
numerous forms, including physical exam notes, laboratory results and pharmacy 
records, but this work is focused on that information encoded by the International 





similar system. These variables consist of 5-digit hierarchical codes, where codes 
sharing the first three or first four digits are likely to involve related diseases. This 
hierarchy creates a correlation structure within these data, yet the methods commonly 
used to model disease burden in ICD-CM data do not account for this structure; nor do 
they attempt to account for any unidentified interactions. Figure 1 shows the hierarchy 
for hypertensive chronic kidney disease within the ICD-9-CM system. All codes 
associated with this condition share the first three digits, while the fourth digit in this 
example indicates whether the disease is benign, malignant, or unspecified. The fifth 
digit further classifies the disease. 
 
Figure 1: Example hierarchy for the ICD-9-CM system. CKD is chronic kidney disease, and ESRD 
is end stage renal disease. 
 
2.3.2 Existing comorbidity summary measures 
 There are several well-known comorbidity summary measures based on the ICD 
system. The Charlson Comorbidity Index is a score based on the sum of seventeen 
weighted comorbidities [1]. Deyo et al., Romano et al., Quan et al. and others developed 
closely-related indices; the newer versions were based on the ICD-9-CM system and 





developed a less parsimonious ICD-9-CM approach for predicting in-hospital mortality 
that defined 31 comorbidities [2]. Elixhauser excluded numerous conditions such as 
those related to the primary diagnosis, acute complications related to treatment, or those 
considered to be unimportant. The Elixhauser index was shown in several studies to be 
more effective than the Charlson Index in predicting in-hospital mortality and one-year 
mortality [2, 9, 10] and today remains one of the most commonly used comorbidity 
indices based on the ICD system. Quan et al. developed enhanced indices that 
corrected inconsistencies in earlier algorithms and provided better accounting for the 
ICD taxonomy, which can frequently lead to the same condition being coded in multiple 
ways.  
 Van Walraven et al. [11] sought to derive a single score to represent the 31 
independent Elixhauser comorbidities, such that it might be easier to develop more 
parsimonious models, particularly for small populations. This approach produced 
weights for each comorbidity based on the relative magnitude of predicted coefficients 
from a multivariate logistic model. Though the authors concluded that neither the 
summary score nor the original Elixhauser index was effective in predicting in-hospital 
mortality, they demonstrated their score’s predictive ability was as effective as the 
original Elixhauser index in adjusting for comorbidities based on the comparison of AUC 
statistics in a dataset of approximately 345,000 hospital admissions. 
 Quan’s enhanced version of the ICD-9-CM Elixhauser index is used throughout 
the first two aims as the primary basis for comparison since it was shown to have 
superior predictive performance over the earlier versions of the Elixhauser index [9], and 





reference to the ‘Elixhauser Index’ throughout this work thus refers to the Quan 
enhanced version of the ICD-9-CM Elixhauser Index unless otherwise indicated. 
 Alemi et al. developed an ICD summary score called the multi-morbidity index 
based on an application of the Naïve Bayes classification model [12]. This index was 
applied in several large Veteran’s Administration populations [13] to predict mortality 
within 6 or 12 months, and the authors compared prediction performance against models 
based on the Quan variant of the Charlson index and the van Walraven variant of the 
Elixhauser index. The AUC for the multi-morbidity index predicting 6-month mortality was 
0.784, compared with values of 0.652 and 0.639 for the Quan-Charlson and van 
Walraven Elixhauser measures. Although this represents a substantial improvement, the 
authors do not demonstrate whether the Naïve Bayes approach was the best for binary 
ICD data, or whether other statistical or machine learning approaches might produce 
superior results.  
 
2.3.3 Choice of classification models 
 The first two aims both involve problems of classification. In the first aim, for 
mortality outcome 1( ,..., y )ny  and binary ICD-9 predictors 1( ,..., )px x , the goal is to find 
an unknown function capable of predicting the outcome: y = f (x). In the second aim, the 
challenge is similar, except that the ICD-9 binary predictor matrix is replaced by a single 
summary score for each patient. Existing comorbidity measures such as the Elixhauser 
or Charlson indices were developed using traditional statistical methods (logistic 
regression and Cox proportional hazards models) with input from clinicians for decisions 





with improved classification performance, numerous approaches were considered, 
including statistical models, machine learning algorithms, and Bayesian methods which 
incorporated both statistical and machine learning elements. Although there were 
dozens of methods to consider (see Hastie et al [14]), the intent was to adapt and test as 
many as feasible, with the goal for finding those with the best classification performance 
in ICD-9 data, and with the additional goal for finding a collection of methods which 
succeeded due to dissimilar strengths. For example: 
1)  Some statistical models may succeed based on their ability to account for the 
correlation structure in ICD-9 data. These data are characterized by hundreds of 
binary features, many of which are sparse, and many are correlated with other 
features. This correlation could be due to the hierarchical structure imposed by 
the ICD system; in other cases it could be due to associations between disease 
conditions not found within the same hierarchy.  
2)  Machine learning methods may succeed due to their ability to automatically 
account for unknown interactions and non-linear relationships between predictors 
[15 – 18]. 
3)  Methods based on an ensemble of models may be more successful. Dietterich 
[19] provided a justification for the observation that ensembles of accurate and 
diverse classifiers often perform better than the individual models. While his work 
helps to explain the success of several machine learning methods, it also justifies 
a model based on the pooled predictions of the successful statistical and 
machine learning methods from the first aim. Dietterich defined an accurate 





diverse classifiers are those with different error rates for the same data. He 
provided three reasons why an ensemble often provides better results than the 
individual classifiers [19]. First, given a hypothesis space, H , each classifier 
provides a hypothesis, with errors associated with the model’s inherent 
characteristics and with the amount of training data provided. When the votes of 
many classifiers are combined, the overall accuracy will likely improve if the 
classifiers are truly diverse. Next, models based on searches over the hypothesis 
space may become fixed on local optima, and an ensemble of models with 
different search paths will likely provide a better overall solution. Finally, although 
H  theoretically contains all possible hypotheses, its size is in practice limited by 
the training data’s dimensions such that the true classification function might be 
excluded from H . When the results of numerous models are combined, perhaps 
in a weighted sum, it may be possible to expand the hypothesis space such that 
the true classification function is found.  
 
2.3.4 Establishing baseline disease burden 
 Each aim involves observational data in which patients were included at the start 
of the study if they met diagnostic criteria for the primary disease (diabetes, chronic 
kidney disease, or traumatic brain injury), and additional patients entered each year of 
the study as they first met the same criteria. Patients were followed until death or the 
end of the study. There was no “dropout” category: patients who had no in-patient or out-
patient visits in a given year were assumed to be alive unless a date of death was found. 





original injury may have occurred in combat, and the injury date would likely only be 
found in the patient’s Department of Defense medical record, which was not available in 
this study. Similarly in other cohorts, the original diagnosis may be recorded by another 
healthcare system. Given these limitations, mortality outcomes were defined based on 
how many years the patient lived after entering the study. Each patient’s set of unique 
ICD-9 codes were collected from the earliest entry in the patient’s VHA record until an 
appropriate cutoff point before death, or until the study’s end, as applicable. For five year 
mortality, this cutoff was arbitrarily set as follows: 
1)  If the patient died within five years of entering the study, the cutoff was set at one 
year prior to death. This excluded codes for conditions that typically occur just 
prior to death, such as palliative care; these conditions are highly associated with 
the outcome but are of less use in making long-term predictions.  
2)  If the patient died after being in the study for more than five years, the cutoff for 
ICD code collection was set at five years after study entry. 
3)  If the patient did not die during the study, the cutoff was set at the study’s end 
date.  
Figure 2 illustrates these limits for two patients (A and B). Regions shaded in red are 
ICD-9 code collection periods for patients A and B. Patient A entered the VA system in 
1985 and entered the study in 2000; patient B entered the VA system in 2003 and 
entered the study at the same time. Patient A died within 5 years of the study’s start 
date, while patient B was still alive 5 years after entering the study and was recorded as 
“alive” in the five-year mortality variable. Patient B’s ICD code collection stopped five 





different total numbers of ICD codes, and the challenge for the models was similar to 
asking, “given everything in the record up until this point, what is the probability the 
patient actually died within five years of entering the study?” For the models to provide 
good predictions, the presence of more or less information for a given patient should not 
lead to bias in either direction. The comparison models based on the Elixhauser index 
faced the same challenge. While there are several possible ways to establish the limits 
described here, this method was found to produce reasonable results.  
Figure 2: Establishing five year mortality and ICD-9 collection periods for a study running between 
2000-2015.  
 
2.3.6 Evaluation of model performance 
2.3.6.1 Evaluation of classification models (Aims 1 and 2) 
 Area under the receiver operating characteristic curve (AUC), sensitivity, 
specificity, positive predictive value (PPV) and negative predictive value (NPV) were all 





for events (patients who died) and non-events (patients who lived) was also considered 
[20]. NRI statistics for the Elixhauser models are not provided since they form the 
reference. While NRI statistics have been widely adopted, Pepe et al. [21] showed they 
should be used with caution. In particular, the authors demonstrated that positive NRI 
results could be achieved in some situations where the new model involved an added 
variable with no predictive value, possibly due to poorly fitting risk models. The AUC and 
related ROC statistics provided reliable results in these situations. Primary emphasis 
was thus placed on the AUC and related statistics; in particular, the NRI result was not 
claimed as evidence for prediction performance improvement unless similar gains were 
seen in the AUC. Finally, the Brier Score provided a measure of misclassification error or 
mean-squared error for binary outcomes [22]. 
 
2.3.6.2 Evaluation of multiple imputation models (Aim 3) 
Imputation methods were compared using the following statistics: 
1) Relative bias: ˆ ˆ ˆ( ) /
o
    , where ̂  and ˆo are the generalized linear model 
parameter estimates based on the imputed data and the full dataset of complete 
cases, respectively. 
2) Efficiency: ˆ ˆvar( ) / var( )
o
    
3) Root mean square error: 
2 2ˆ ˆ ˆ( )o    , where 2̂ is the estimated variance of the 
parameter estimate from the model based on imputed data. 
4) Coverage probability: the probability based on 1000 bootstrapped iterations that the 








2.3.7 Missingness in VHA data 
 Missing data in key VHA variables such as race/ethnicity poses a substantial 
problem for investigators involved in healthcare inequities. Further, several investigators 
have reported missing race information in VHA or Medicare data may not be missing at 
random [4 – 6]. Depending on the timeframe being studied, the level of missingness may 
be substantial. Stroupe et al. [23] reported that 48% of VHA patient records had missing 
race-ethnicity information in 2004, but this value had been reduced to 15% by 2012 [3] 
due to concerted efforts to collect this information and due to a 2003 requirement for 
recording self-reported race-ethnicity rather than observer-reported values [24].  Stroupe 
et al. [23] demonstrated that further improvements were possible by merging VHA data 
with Medicare data; in the author’s experience with several VHA cohorts followed 
through 2012 or later, the missing race fraction can now be reduced to below 5%. 
However, the missing race-ethnicity problem is far from solved: even at these lower 
levels, if the data are believed to be missing due to non-random processes, investigators 
must still be concerned whether unbiased results were achieved. Further, studies 
involving patients who were not followed in recent years will likely still face substantial 








2.3.8 Existing multiple imputation methods 
 In past years, researchers often dealt with the missing data problem by simply 
conducting complete-case analysis, though this strategy could lead to biased results 
unless the data were missing completely at random. More recently, steps to attempt to 
assess the pattern of missingness and methods to help achieve unbiased results are 
commonly seen. Numerous parametric imputation methods exist for handling data with 
missing completely at random (MCAR) or missing at random (MAR) patterns; multiple 
imputation with by chained equations (MICE) is one commonly used approach due to its 
ability to handle multiple imputation for mixed data types [25, 26]. MICE imputes missing 
values from separate conditional distributions for each variable with missing values, but 
has been criticized for lacking a theoretical basis [27], and for requiring the investigator 
to have advance knowledge of non-linear relationships or collinearities between 
predictors  [17]. Other researchers have concluded that machine learning methods can 
automatically handle interactions and other concerns while also producing inference 
estimates with narrower confidence limits and with more computational efficiency. The 
random forest algorithm has been applied in several multiple imputation research efforts, 
and involves bootstrap aggregation of numerous independent decision trees, and can 
account for complex interactions and collinearities between predictors more readily than 
many parametric methods, while the ensemble voting of independent trees naturally 
lends itself to an efficient imputation process [28]. For example Stekhoven et al. [16] 
claim their multiple imputation approach (missForest) based on the random forest 
method was superior to traditional statistical methods including MICE, based on 





al. [29] provided a similar conclusion based on a comparison of machine learning and 
statistical imputation methods.  Other researchers have incorporated machine learning 
methods within an existing statistical method. For example, Shah et al. [17] incorporated 
random forest as the multiple imputation method within the existing MICE method and 
showed the new approach had a superior ability to handle nonlinear relationships and 
collinearities.  
 
2.3.9 Evaluating missing not at random (MNAR) situations 
 Though the multiple imputation methods described above are capable of 
producing unbiased results under MCAR and MAR, such results are far less likely under 
MMAR. As Verbeke et al. [30] discuss, it is possible to construct models based on 
MNAR assumptions, but these assumptions are not testable since their support is not 
contained in the data. Further, Molenburghs et al. [31] demonstrated that it is not 
possible to empirically distinguish between MNAR and MAR situations from the data 
alone because for every MNAR model, it is possible to build an MAR model with the 
same fit. The most common approach given these circumstances is to conduct 
sensitivity analysis on MAR models to examine their stability when MNAR assumptions 
are introduced [32, 33] Though numerous approaches are possible, two general types of 
sensitivity analyses are most common; these are based on pattern mixture models [32 – 
34] and selection models [35].  
 A pattern mixture model assumes that a number of missingness patterns may 
exist, each with a separate joint distribution for the partially and fully observed variables. 






iR , such that 0iR when 1iY is missing and 0iR otherwise. Under MNAR the 
joint distribution 1 2i i if (Y ,Y ,R )  is factored as 1 2i i i if (Y ,Y | R ) f(R ) , where the joint distribution of 
the partially and fully observed variables is conditional on the partially observed variable. 
Since the MNAR distribution cannot be determined from the observed data, Carpenter 
and Kenward [32] suggest starting from the MAR scenario and then adjusting the model 
using MNAR assumptions in order to examine whether the MAR assumption is sensitive 
to such changes.  
  A selection model, on the other hand, factors the joint distribution 1 2i i if (Y ,Y ,R )  
differently; now the focus is on the mechanism behind the MNAR process: 
1 2 1 2 1 2i i i i i i i if (Y ,Y ,R ) f ( R |Y ,Y ) f (Y ,Y ) . Numerous methods are based on this factorization; in 
the third aim, a weighting approach is applied [36]. 
  
2.3.10 Resampling Methods (Aims 1 - 3) 
Resampling methods were applied for several reasons:  
1)  Some methods, including Bayesian additive regression trees and random forest 
could not be run in a reasonable amount of time on large datasets involving millions 
of patients without resorting to a parallel computing environment. Instead, a 
resampling approach was used to generate model performance estimates. For 
example, in the first aim, 1000 smaller test and training datasets of 5000 
observations each were generated by randomly sampling the full datasets with 





overall mean and 95% confidence intervals generated by 1000 iterations were used 
to compare the models’ relative performance.  
2)  In simulations, a resampling approach was used to generate large numbers of 
independent training and validation datasets from actual VHA data rather than 
relying on fully-generated data. This helped to ensure that the complex structures 
and associations found in real patient observations were also present in synthetic 
datasets. This was particularly important due to the complex correlation structure in 
ICD-9 data. As demonstrated by Marshall et al. [37] and Gebregziabher et al. [38] 
this approach is reasonable when the original dataset is large enough to help assure 
independence between samples.  
 
 When applying resampling methods, steps were taken to ensure full 
independence between training and validation datasets. In the first aim, training and 
validation datasets were generated in pairs during each iteration, with steps taken to 
ensure no observations were common to the two sets during the bootstrapping process. 
In the second aim, 1000 training data sets were used to determine variable importance 
measures, which were then used to determine the comorbidity score. The score, in turn, 
was tested on 1000 validation data sets. Because the validation step took place after all 
of the training datasets had been analyzed, it was necessary to randomly partition the 
full dataset such that training data was drawn from one subset, and validation data from 









This research made new contributions in the following areas: 
1)  Although other research has compared traditional statistical methods and machine 
learning approaches in the development of predictive models for specific disease 
conditions [39 – 44], to the best of the author’s knowledge, this is the first effort to 
conduct a detailed application of such methods in the development of improved ICD- 
based disease burden models (aim 1) and an improved ICD-based summary score 
(aim 2). In the first aim, the best models (Bayesian additive regression trees, random 
forest, elastic-net and the pooled model) consistently had better predictive 
performance when compared with the Elixhauser index. Similarly in the second aim, 
the comorbidity summary score for predicting five-year mortality had stronger 
predictive performance than the widely-used Elixhauser index. 
2)  This research provided a comprehensive comparison of multiple imputation methods 
under both MAR and MNAR conditions, and in particular, developed new 
applications for applying machine learning methods within the multiple imputation 
with chained equations (MICE) framework. Additionally, several MNAR sensitivity 
methods were adapted and applied, both in simulations and in actual data, to 
demonstrate that unbiased inference may not be possible in some MNAR scenarios, 
even when the missingness mechanism is fully understood. This result has direct 








3.  First manuscript: Comparison of Statistical and Machine Learning Methods for 
Developing Improved Comorbidity Models Based on the ICD System 
 
3.1  Introduction 
 When conducting healthcare outcomes research, accounting for disease burden 
is essential for reducing the potential for bias in estimating the association between 
outcomes and risk factors. For example, researchers designing studies to examine 
disparities between racial and ethnic groups with diabetes must first account for each 
patient’s other diseases and conditions; otherwise, the study is not likely to produce 
meaningful results. Since this research frequently involves administrative healthcare 
databases or electronic health records, this effort will become increasingly important as 
the availability and quantity of such data continues to rapidly expand.  
 In administrative healthcare data, comorbidity information is found in numerous 
forms, including physical exam notes, laboratory results and pharmacy records, but this 
paper is concerned with that comorbidity information encoded by the International 
Classification of Diseases, Clinical Modification (ICD-9-CM or ICD-10-CM), or by a 
similar system. These variables consist of hierarchical codes. For example, in the ICD-9- 
system, codes sharing the first three or first four digits are likely to involve related 
diseases. This hierarchy creates a correlation structure, yet the methods commonly used 





attempt to account for any unidentified complex interactions and frequently do not 
consider disease severity.  
 There are several well-known comorbidity summary indices based on the ICD 
system. The Charlson Comorbidity Index [1] is a single score based on the sum of 17 
weighted comorbidities. Deyo et al. [45], Romano et al. [8], Quan et al. [9] and others 
developed closely related indices based on the same 17 comorbidities. In contrast to the 
Charlson’s single summary score, Elixhauser et al. [2] developed a more complex index 
that consisted of 31 distinct comorbidities. Because the outcome was in-hospital 
mortality, Elixhauser excluded conditions related to the primary diagnosis, acute 
complications related to treatment, or those considered unimportant. The Elixhauser 
index was shown in several studies to be more effective than the Charlson Index for 
predicting in-hospital mortality and one-year mortality and today remains one of the most 
commonly used comorbidity indices based on the ICD system [2, 9,10]. Quan et al. [9] 
developed enhanced indices that corrected inconsistencies in earlier algorithms and 
added improved accounting for the ICD taxonomy, where the same condition might be 
coded in several ways. Quan’s enhanced version of the ICD-9-CM Elixhauser index is 
used as the basis for comparison here since it was shown to have superior predictive 
performance over the earlier versions [9].  
 Kheirbek et al. [12] developed an ICD summary score called the multi-morbidity 
index based on an application of the Naïve Bayes classification model. This index has 
been applied in several large Veteran’s Administration populations to predict mortality 
within 6 or 12 months [13]. The multi-morbidity index’s prediction performance was 





and the van Walraven variant of the Elixhauser index [11]. However, the authors only 
considered the naïve Bayes approach, and did not demonstrate whether other statistical 
or machine learning methods might produce superior results. Similarly, Siddique et al.     
[46] relied on a single method (classification trees) to develop an ICD-9-CM based 
algorithm for predicting which patients had lower gastrointestinal bleeding.  
  This work is based on the premise that advances in computing power, machine 
learning and statistical methods since the Elixhauser Index’s introduction in 1998 will 
support the development of improved ICD-based models with better predictive 
performance. Seven statistical and machine learning methods for the analysis of high 
dimensional data with binary ICD-CM predictors are compared. These methods apply 
various approaches that were not considered in the Elixhauser index’s development, 
including (1) empirically identifying latent features, (2) accounting for the inherent 
hierarchical structure in ICD-CM data, (3) automatically incorporating complex 
interactions, and (4) attempting to account for disease severity. Although other research 
has compared traditional statistical methods and machine learning approaches in the 
development of predictive models for specific disease conditions [39 – 44], to the best of 
the author’s knowledge, this is the first effort to conduct a detailed comparison of such 
methods in the development of an improved ICD-CM based comorbidity summary 
measure.  
 This research is focused on the ICD-9-CM rather than the ICD-10-CM system 
because it involves Veteran’s Administration data recorded under the ICD-9 system, 






3.2  Study Design and Methods 
 This study was conducted in two phases. In the first phase, the seven methods 
described below were applied, each in separate models for two populations. The 
outcome was mortality within the study’s timeframe, and no ICD-9 codes were excluded 
based on their temporal proximity to the patient’s death. Each model’s predictions were 
compared to those from models based on the Elixhauser-Quan comorbidities derived 
from the same ICD-9 data. Each model was trained using a single-disease population 
and was validated using other patients drawn from the same population. In the second 
phase, the top four models based on predictive performance from the first phase were 
used to examine whether performance varied when the outcome was shifted to five-year 
mortality instead of death within the study’s timeframe. Further, ICD-9 codes recorded 
within one year of death were excluded since these might provide an unrealistic 
advantage over the Elixhauser-Quan index. For example, the ICD-9 code for palliative 
care is strongly associated with death but may not be useful for predicting mortality 
several years in the future. Finally, in the second phase each model was again trained in 
a single-disease population, but was now validated on a combined population equally 
drawn from the traumatic brain injury and diabetes groups in order to examine how well 
they each performed in a more general setting with a wider range of comorbidities. 
 
3.2.1 Populations 
Two national cohorts of U.S. Veterans were used; these had been created for 
earlier studies by linking numerous Veterans Health Administration patient and 





based on two or more related ICD-9-CM codes and at least one prescription filled for a 
medication to treat diabetes [47]. In the original study, Veterans were followed from 2002 
until death, loss to follow-up, or until December 2006, and newer data was added to 
extend the follow-time until December 2012. The second cohort involved 168,125 
Veterans diagnosed with traumatic brain injury (TBI) during 2004 and 2005. In the 
original study, patients were followed from the point of entry until death, loss to follow-up, 
or until December 2010 [48]; newer data were added to extend the follow-time to 
December 2014. Both studies were approved by the Medical University of South 
Carolina Institutional Review Board (IRB) and the Ralph H. Johnson Veterans Affairs 
Medical Center Research and Development committee. 
 
3.2.2 Patient demographic and clinical covariates 
Models termed ‘unadjusted’ used only on ICD-9 predictors; those termed 
‘adjusted’ also controlled for each patient’s demographic and clinical covariates. In both 
cohorts, the patient’s age in years was treated as a continuous variable. Race and 
ethnicity were categorized as non-Hispanic white, non-Hispanic black, Hispanic, and 
other / missing. Gender and marital status were treated as binary variables. In the TBI 
cohort, homeless status was treated as a binary variable. TBI severity was categorized 
as ‘not severe’, ‘moderately severe’, and ‘severe’. A binary variable was used to indicate 
if the TBI injury was related to military service. The patient’s location was categorized 
over the five Veterans Administration (VA) regions. The patient’s location by Rural Urban 





Finally, the availability of poly-trauma treatment centers by VA station and by VA 
integrated service network (VISN) were each included as binary variables. 
 Prior to analysis, erroneous duplicate formats of ICD-9 codes were identified and 
corrected to the single correct format. For example, codes 250, 2500, and 25000 all 
represent the same condition, but each would be treated as separate predictors in 
machine learning algorithms. Next, the listing of unique ICD-9 codes gathered from all 
patients was ranked by frequency. The 1000 most frequent codes formed the feature set 
used in subsequent analyses, and this listing accounted for approximately 90% of all 
ICD-9 codes recorded among all patients in the respective datasets.  
 
3.2.3 Outcomes 
 In the first phase, the outcome was death within the study window; in the second 
phase, the outcome was five-year mortality.  
 
3.2.4 Methods 
Each phase was conducted in two parts: (i) first prediction models were 
developed using training datasets; (ii) each prediction model was then validated using 
test data. Since computational efficiency was a concern for some methods due to the 
very large datasets involved, resampling methods were used to generate 1000 smaller 
test and training datasets of 5000 observations each by randomly sampling the full 
datasets with replacement. Performance statistics were collected for each validation run, 
and their mean and 95% confidence intervals were determined over 1000 iterations. As 





bootstrapping approach is reasonable for these large datasets, such that independence 
between numerous samples is reasonably assured. 
 
3.2.4.1 Generalized linear model with penalized maximum likelihood (elastic-net 
regression):  
 Several penalized generalized linear models were considered, including ridge 
regression [50], LASSO regression [51], elastic-net regression [52], and group LASSO 
regression [53]. Elastic-net regression provided the best predictive performance in the 
ICD-9-CM datasets. The elastic-net model incorporates both the LASSO and ridge 
approaches with the addition of parameter  such that the loss function becomes the 
LASSO model when   is 1, and the ridge model when   is 0. An iterative process 
showed that  = 0.5 provided the best predictive performance. For binary outcome
( 1,1)y  , predictors 1 1,: (1, ,..., )i i p ix x x   and shrinkage parameter  , the following 
equation was minimized in order to determine coefficient estimates [14]:   
𝑚𝑎𝑥
𝛽0, 𝛽
 [∑ {𝑦𝑖(𝛽0 + 𝛽
𝑇𝑥𝑖) − log(1 + 𝑒
𝛽0+𝛽




The R package glmnet [54] was used to determine parameter estimates based on the 
training data, and then used these estimates to generate predictions in the test data. 
 
3.2.4.2 Model averaged regression coefficients (MARC):  
 This model is based on adapting a method developed by Glance et al. [55] for 
their Trauma Mortality Prediction Model. This approach attempted to account for the 
correlation structure created by the ICD-9-CM hierarchy. The first step involved creating 





code as it appears in the data. For the second model, Glance et al. relied on a separate 
scale for trauma location and severity to group related injuries into higher level ‘bins’. 
This would not be practical here since the models include every unique disease code 
rather than a limited set of trauma injuries. Instead, each ICD code was collapsed to its 
first three digits, thereby combining all information for a given hierarchy of related 
comorbidities into a single high-level variable. The estimated coefficients for the two 
models were then combined using an inverse variance weighting approach such that the 
high-level model coefficients were weighted more when the variance of the 
corresponding coefficient estimate was lower than that for the full model. Thus, when 
there was little information about a particular comorbidity (and thus a higher estimated 
coefficient variance), information from the related comorbidities in the hierarchy was 
given a stronger weight.  
 The full model, which relied on the 5 digit ICD-9-CM code, was written: 
 
1000
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 , 
where   is the probit link, i ix  and  are the coefficient and binary indicator for the 
thi  
ICD-9-CM code, and i  is the coefficient for a given patient covariate. 
 The high-level model, which collapsed data to the first three digits of the ICD-CM 
code, was written: 
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where j jz  and  are the 
thj  coefficient and binary indicators for the J high level ICD-
CM variables created when the ICD-CM codes were collapsed to the highest level. The 
parameter estimates from the two models were combined using weighted inverse 
variances to produce a Model Averaged Regression Coefficient (MARC) for each of the 
top 1000 ICD-CM predictors. That is, 
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where var( ˆ )j  is a weighted variance of the ˆ 'i s  that map to a specific 
ˆ
j , where each 
ˆ 'i s contribution to the overall variance was weighted by its inverse variance [55]: 
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Finally, new predictions were made using test data and the sum of each patient’s MARC 
values associated with their ICD-9-CM codes. In summary, the MARC values were 
determined from training data, and were then applied in test data for new patients in the 
validation model: 






3.2.4.3 Naïve Bayes Variable Selection (multi-morbidity index) 
 Kheirbek et al. [12] developed an ICD summary score called the multi-morbidity 
index based on an application of the Naïve Bayes classification model. For binary 
random variables 1( , , ,... )r dX X XX =  sampled from a population classified by two 
categories ( i  or j ), the odds of outcome i  occurring are: 
( | ) ( | ) (i)
.
( | ) ( | ) ( )
P i x P x i P
P j x P x j P j
  
Each random variable is assumed to be independent of the others: 
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The posterior probability for outcome i  can be easily calculated from the posterior odds 
above. The assumption of independence among the predictors in X  is questionable, 
and Hand et al. [56] discuss reasons why this approach is nonetheless often successful. 
In particular, the authors argue that although the Naïve Bayes approach may produce 
biased estimates, the variance for such estimates is often lower than seen in less 
parsimonious models. Further, for classification purposes such bias is not a hindrance 
as long as it is in the right direction. Kheirbek et al. made several necessary 
accommodations in order to apply the Naïve Bayes approach to ICD-9 data. For 
perfectly separated predictors, the posterior odds were arbitrarily defined as 1 1n  
when all patients died and 1n  when all patients survived, where n  is the number of 
patients with a given ICD-9 code. Next, when the number of patients with a given ICD-9 





combined based on the assumption that related conditions have similar associations 
with the outcome of interest. 
 
3.2.4.4 Association Rules Analysis [14]: 
  This is an unsupervised machine learning method concerned with finding joint 
values of predictors  1, 2, ... pX X X  that appear most often in the data. Because ICD-9-
CM data is binary, the support for each jX  is S {0,1} , and the goal is to find 









where s is a single value of the support for jX . Next, the conjunctive rules are 
transformed to become: 
Pr ( 1) Pr ( 1)
p
k kk Kk K
Z Z

         ,  
where kZ represents a binary dummy variable formed from one level of jX . The set of 
predictors in conjunctive rule K is called the item set, and the number of kZ variables in 
the set is known as the size. The estimated value for a conjunctive rule is called the 













where ikz is the value of kZ  for the 
thi observation. T  thus represents the proportion of 
observations which contain the conjunctive rule. When the item set K  is divided into two 
parts, such that antecedent A  predicts the presence of consequent B , ( )T K  becomes








  . 
When the predictors which make up A  appear in an observation, the confidence value 
represents the probability that predictor B  will also appear. Hastie et al. [14] comment 
that association rules analysis is very good at finding combinations of variables that 
appear frequently, but is less good at finding those with lower support. Thus we would 
not expect to identify a joint occurrence that included at least one rare ICD-9-CM 
diagnosis, even if this joint occurrence were strongly associated with the outcome.  
 The R package arules was used to implement association rules analysis [57]. 
Prevalence and confidence thresholds t and c were set to limit the number of rules 
returned by the algorithm: 
( ) tT A B   and ( )C A B c  . 
Because this is an unsupervised method, joint occurrences were identified without 
regard to the outcome of interest. Each candidate rule was tested for significance 
against the outcome on a univariate basis using a different set of training data than that 
used to generate the association rule. Multiple testing was accounted for during this 
process using the Bonferroni adjustment, such that the critical value for significance 





regularized logistic regression was used to help determine which rules were most 
important in predicting the outcome. The resulting association rules and their parameter 
estimates were then used to make predictions for other patients in a test data set.  
 
3.2.4.5 Random Forest (RF)  [28] 
  This is a well-known ensemble method based on classification trees that relies 
on bootstrap aggregation (or ‘bagging’) to generate a forest of generally uncorrelated 
trees, where each tree then votes for the predicted outcome. The forest is termed 
“random” due to the random selection of a pre-specified number of features (or predictor 
variables) at each node; the feature that leads to the largest improvement in the tree’s 
classification ability is then used to split the data at that node. The random forest method 
can identify complex interactions, and was reported to be very competitive with other 
machine learning methods when compared on the basis of misclassification error [14]. 
The R package randomForest was used to implement this method [58]. A forest was 
generated using patients in a training dataset, which was then used to make predictions 
on other patients in test data. 
 
2.4.6 Bayesian Additive Regression Trees (BART) [59] 
  This is an extension of the supervised tree-based ensemble learning method, 
but unlike random forest, prior distributions are established for each tree’s decision rules 
and terminal node parameters, and an MCMC algorithm is used to sample from the 
posterior distribution for the ensemble of trees. The authors contend their approach 





reduced. They also claim that the predictive results in some datasets were superior to 
random forest, neural nets, and regularized regression methods [59]. For a BART model 
with binary outcome Y , a probit model is used: 
[ 1| x] [ ( )]P Y G x   , 
where x represents the data and ( )G x  is a summation of m trees, where the 
thj  tree is 
designated as ( ;T , )j jg x M  : 
1




G x g x T M

 . 
Here, T and M are the tree’s decision rules and terminal node parameters, respectively, 
and each is assumed to have independent and identical prior distributions. The prior for 
jT  is defined in multiple parts. First, the probability that a given node of depth d is non-
terminal is (1 )d   , for (0,1), [0, )    . Values of 0.95 and 2 were selected for 
  and  , respectively in order to help limit each tree’s size. Finally, uniform priors were 
used to model the splitting variable and splitting rule assignments for interior nodes in 
each jT . For jM , a Gaussian prior distribution is assumed for the mean value ij  for 
terminal node i within tree j: 
2~ (0, )ij N   , where 3.0 / k m  , 
where m is the number of trees, typically 200, and k is a parameter typically set between 
1 and 3. This prior serves to limit the values of G(x) to within (-3.0, 3.0), and thus shrinks 





 The R package BayesTree was used to implement BART [60]. This algorithm 
develops the model based on the training data, and then provides the results of post-
convergence samples from the posterior distribution using test data. The mean or 
median of these samples is then used to provide a prediction for each test set 
observation. The algorithm also returns the number of times each predictor is used in a 
decision rule among all trees; this serves as a variable importance measure.  
 
3.2.4.7 Pooled prediction model  
 An ensemble model was developed based on the combined predictions from all 
of the models considered. Here each model’s test data predictions were used as 
independent predictors in a logistic model using the same test data. The predictive 
performance of this combined model was then compared against the other six models. 
 
3.2.4.8 Elixhauser-Quan comparison model 
  Each of the above approaches was compared against a model based on the 31 
independent Elixhauser-Quan comorbidities: 
  
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where iC  is the estimated coefficient for the ith comorbidity from the enhanced 







3.2.4.9 Model Performance Assessment 
 Area under the receiver operating characteristic curve (AUC), sensitivity, 
specificity, positive predictive value (PPV) and negative predictive value (NPV) were all 
considered when comparing models. Net reclassification improvement (NRI) was also 
reported for events (patients who died) and non-events (patients who lived) [20]. While 
NRI statistics have been widely adopted, Pepe et al. [21] showed they should be used 
with caution. In particular, the authors demonstrated that positive NRI results could be 
achieved in some situations where the new model involved an added variable with no 
predictive value, possibly due to poorly fitting risk models. The AUC and related ROC 
statistics provided reliable results in these situations. Primary emphasis was thus placed 
on the AUC and related statistics; in particular, a strong positive NRI result was not 
claimed as evidence for prediction performance improvement unless similar gains were 
seen in the AUC. Finally, the Brier Score was reported as a measure of misclassification 
error [22]. 
 
3.3.  Results 
 Table 1 provides demographic information for the two populations examined in 
this study and Figure 3 provides the percentage of each group diagnosed with each of 
the 31 Elixhauser comorbidities. The DM cohort was older than the TBI group (mean age 
73.1 versus 49.9), and had a higher five-year mortality rate (13.3% versus 4.4%). The 
DM cohort had higher rates of congestive heart failure, peripheral vascular disorders, 




















Gender (%) male 97.0 93.7 
 
female 3.0 6.3 
Marital status (%) single 7.0 26.0 
 
widowed 11.0 4.6 
 
divorced 21.0 25.9 
 
married 59.0 42.1 
Race/ethnicity (%) Non-Hispanic white 76.0 55.8 
 
Non-Hispanic black 15.0 13.0 
 
Hispanic 5.0 1.9 
 




Greater than 50% disability (%) (service-connected) 27.0 23.3 
 
The TBI cohort had substantially higher rates of depression, psychoses, drug abuse, 
alcohol abuse, liver disease, and neurological disorders. 
 Table 2 provides a comparison of validation results for the DM and TBI cohorts 
for the seven models that were compared against the Elixhauser-Quan model in phase 
1, and Figures 4 and 5 provide a corresponding graphical comparison of confidence 
intervals for each statistic based on 1000 iterations. Results labeled “unadjusted” 
correspond to models in which only ICD-9-CM codes were used as predictors, while 
“adjusted” models also included patient demographic variables. Overall, the BART, 
random forest, elastic-net and pooled models had the best predictive performance as 
seen in their consistently higher mean AUC values and lower Brier scores for unadjusted 







Figure 3:  Prevalence of the 31 Elixhauser-Quan comorbidities in the diabetes and traumatic brain 
injury cohorts 
 
models were less successful when compared to the Elixhauser-Quan model, particularly 
in the TBI population. In the TBI cohort, mean AUC values for unadjusted models varied  
between 0.83 and 0.92, compared with 0.83 for the Elixhauser-Quan model. In the DM 
cohort, they varied between 0.68 and 0.78, compared with 0.64 for Elixhauser-Quan 
model. In general, net reclassification statistics for predicting mortality (NRI (event)) for 
top-performing models were improved compared to the Elixhauser-Quan model, but NRI 






Table 2:  Mean performance statistics for Phase 1 models from validation data for the diabetes 
and traumatic brain injury cohorts based on 1000 replications. Unadjusted models were based 
only on ICD predictors, while adjusted models also included other patient demographic and 
clinical variables. The outcome was death within the study timeframe. 
 
















unadj. 0.64 0.68 0.71 0.72 0.75 0.75 0.77 0.78 
adj. 0.77 0.78 0.80 0.80 0.82 0.82 0.82 0.84 
adj. 0.73 0.74 0.76 0.75 0.77 0.78 0.78 0.79 
NRI 
(event) 
unadj. ref 0.11 0.10 0.10 0.20 0.22 0.27 0.29 
adj. ref 0.04 0.07 0.03 0.09 0.12 0.12 0.14 
NRI 
(nonevent) 
unadj. ref -0.05 -0.01 -0.02 -0.04 -0.05 -0.05 -0.05 
adj. ref -0.02 -0.01 0.03 0.00 -0.01 0.00 0.01 
Brier Score 
unadj. 0.23 0.22 0.21 0.21 0.20 0.20 0.19 0.19 
adj. 0.19 0.18 0.17 0.18 0.17 0.17 0.16 0.16 
















unadj. 0.83 0.83 0.83 0.87 0.92 0.91 0.91 0.92 
adj. 0.87 0.89 0.88 0.88 0.92 0.92 0.91 0.93 
NRI 
(event) 
unadj. ref 0.14 0.06 0.20 0.22 0.27 0.24 0.27 
adj. ref 0.03 0.00 0.00 0.10 0.14 0.10 0.12 
NRI 
(nonevent) 
unadj. ref -0.03 -0.02 -0.10 0.01 0.00 0.00 0.00 
adj. ref 0.00 -0.01 -0.02 0.01 0.00 0.01 0.01 
Brier Score 
unadj. 0.13 0.13 0.13 0.13 0.09 0.09 0.09 0.09 
adj. 0.11 0.11 0.11 0.11 0.09 0.09 0.09 0.08 
 
predict which patients would die, but no improvement for predicting which patients would 
survive.  
 Table 3 and Figure 6 provide the results from phase 2, where the top-performing 







Figure 4: Diabetes Cohort performance statistics are shown for the unadjusted (in black) and 
adjusted (in red) phase 1 models, with 95% confidence intervals based on 1000 iterations. 
Adjusted models are based on both ICD code predictors and patient demographic variables, 
while unadjusted models are based only on ICD code predictors. The outcome was death within 
the study timeframe. NRI values for the Elix-Quan models are 0.00 since they serve as the 
reference. 
 
outcome was five-year mortality rather than death within the study’s timeframe, and ICD 
codes recorded within one year of death were excluded in order to avoid favoring  
conditions such as palliative care that would be strongly associated with death but would 
provide little long term predictive ability. As in phase 1, each model was trained in a 
single-disease dataset but was validated on a combined dataset comprised of the DM 






Figure 5: Traumatic Brain Injury Cohort: performance statistics are shown for the unadjusted (in 
black) and adjusted (in red) phase 1 models, with 95% confidence intervals based on 1000 
iterations. Adjusted models are based on both ICD code predictors and patient demographic 
variables, while unadjusted models are based only on ICD code predictors. The outcome was 
death within the study timeframe. NRI values for the Elix-Quan models are 0.00 since they serve 
as the reference. 
 
general population with a wider range of comorbidities. Phase 2 included only ICD codes 
as predictors since the phase 1 results demonstrated that adjusted for other covariates 
did not provide additional predictive performance insights. The BART, RF, elastic-net 
and pooled models were again superior to the Elixhauser model as seen in consistently 
higher mean AUC values and lower Brier scores for unadjusted and adjusted models in 





Table 3: Mean performance statistics from validation data for phase 2 models for diabetes and 
traumatic brain injury cohorts based on 1000 replications. Each model was trained on a single-
disease dataset but was validated on a combined group drawn equally from the DM and TBI 












Diabetes cohort (training) with combined cohort (validation) (Phase 2) 
AUC 0.74 0.85 0.84 0.83 0.86 
NRI 
(event) 
Ref 0.08 0.10 0.10 0.16 
NRI 
(nonevent) 
Ref -0.01 -0.01 -0.01 -0.01 
Brier Score 0.07 0.07 0.07 0.07 0.06 
TBI cohort (training) with combined cohort (validation) (Phase 2 ) 
AUC 0.74 0.89 0.88 0.83 0.89 
NRI 
(event) 
Ref 0.27 0.23 0.20 0.29 
NRI 
(nonevent) 
Ref -0.02 -0.02 -0.01 -0.02 
Brier Score 0.07 0.06 0.06 0.06 0.06 
 
 
were seen in predicting mortality but little improvement was seen in predicting survival. 
In the TBI cohort, mean AUC values varied  
between 0.83 and 0.89, compared with 0.74 for the Elixhauser-Quan model. In the DM 
cohort, AUC values varied between 0.83 and 0.86, compared with 0.74 for Elixhauser-
Quan model. Table 4 provides a summary of comorbidities that were important 
predictors of five-year mortality but which were not accounted for by the Elixhauser-
Quan index. These comorbidities were identified by finding the common group of ICD-9-






Figure 6:  Phase 2 model mean performance statistics are shown with 95% confidence intervals 
based on 1000 iterations. Each model was trained on a single-disease dataset but was validated 
on a combined group drawn equally from the DM and TBI datasets. All models were unadjusted, 
based only on ICD predictors. The outcome was five-year mortality 
 
which were not included in the Elixhauser index definition, were associated with mortality 
rather than survival, and were ranked in the top 50% for variable importance by each 









Table 4: Summary of comorbidities from phase 2 models which were found to be important 
predictors of five-year mortality but were not accounted for by the Elixhauser-Quan index. These 
comorbidities were identified by finding the common group of ICD-9-CM codes associated with 
mortality in the RF, elastic-net, and BART models for both the TBI and DM populations that were 
consistently ranked in the top 50% for variable importance. This list was further narrowed to 
include only those conditions not accounted for by the Elixhauser-Quan index. Many of the below 





07051 Acute hepatitis C 
29048 Vascular dementia 
2948 Other persistent mental disorders 
3310 Alzheimer's disease 
4111 Intermediate coronary disease 
41400 Coronary atherosclerosis of unspecified type of vessel 
4293 Cardiomegaly 
436 Acute but ill-defined cerebrovascular disease 
43889 Other late effects of cerebrovascular disease 
5234 Chronic periodontitis 
5251 Loss of teeth 
5939 Disorder of kidney and ureter, unspecified 
600 Hyperplasia of prostate 
7070 Pressure ulcer 
7809 Altered mental status 
7866 Swelling, mass, or lump in chest 
7872 Dysphagia 
7993 Debility, unspecified 
V048 Need for prophylactic vaccination against viral diseases 
V604 No other household member able to render care 
V651 Person consulting on behalf of another person 







3.4  Discussion  
 This work compared the performance of seven approaches for predicting patient 
outcomes based on comorbidities derived from ICD-9-CM codes. To the best of the 
author’s knowledge, this is the first effort to conduct a detailed comparison of statistical 
and machine learning methods in the development of an improved prediction model 
based on the ICD system. In the first phase, the outcome was death within the study’s 
timeframe, and no ICD-9 codes in the patient’s record were excluded from consideration.  
Models were validated with observations for other patients drawn from the same cohort. 
The second phase involved a more robust evaluation of the top-performing models from 
the first phase. The outcome was five-year mortality, ICD-9 codes recorded within one 
year of death were excluded, and models were validated on a combined dataset drawn 
from both disease populations.  
 In both phases, the BART, RF, elastic-net and pooled models consistently had 
better predictive performance compared to models based on the Elixhauser-Quan index. 
Each method may have succeeded due to different strengths, of which none were seen 
in the Elixhauser-Quan approach. The pooled model, which attempted to merge the 
strengths from individual models, appeared to offer the best results in both phases and 
in both populations. This is consistent with conclusions that ensemble methods often 
outperform any single classifier [19]. The elastic-net model provided a balanced 
approach for handling possible collinearities between ICD-9 predictors while also 
shrinking less important estimated coefficients towards zero. The successful machine 
learning approaches (RF and BART) may automatically account for complex interactions 





attempted to account for a condition’s relative severity rather than considering each to 
be an equally weighted and independent predictor.  
 Though the phase 2 models involved greater prediction challenges due to the 
shift to five-year mortality, the exclusion of ICD-9 data within a year of death, and the 
use of a wider population for validation, no substantial loss in predictive performance 
was seen. Mean AUCs for unadjusted DM models improved in phase 2 by 6% to 10%, 
while mean AUCs for unadjusted TBI models were 3% to 8% lower than for the 
corresponding phase 1 model. In all cases, each model had substantially better 
predictive performance when compared to the corresponding Elixhauser-Quan models. 
This provides some evidence these methods could be generalized to a wider population 
and to a range of different outcomes. 
 In addition to improved predictive performance, the phase 2 results provided 
additional insights into the patient populations beyond those provided by the Elixhauser 
index. As seen in Table 4, the patient’s functional status was an important predictor of 
five-year mortality not accounted for by the Elixhauser-Quan model; examples of these 
conditions include cognitive problems, pressure ulcers, and caregiver status. This 
conclusion concerning functional status is consistent with previous research [61, 62]. 
Other serious conditions not included in the Elixhauser-Quan index were also identified; 
examples include Alzheimer’s disease, cardiomegaly, and acute hepatitis C. These were 
likely excluded from the Elixhauser Index because they were not highly associated with 
the short-term outcomes used in its development. 
 Although the  pooled model is based on a simple logistic regression, efforts to 





lead to any improvements.  For example, the prediction densities from the BART, RF 
and elastic net models were plotted separately for true positive, false positive, true 
negative and false negative training data observations under the pooled model.  
Differences in respective densities between the four groups were used to adjust the 
pooled model predictions, but this led to a slight drop in predictive performance.  For 
example, any prediction improvement in the false negative group was negated by a 
decline in the true negative group. 
 There are several important limitations. First, this work was limited to two 
populations of generally older, male Veterans, and it was not demonstrated whether 
these methods would achieve similar results in other groups. Next, the use of 
administrative data imposes substantial risks for measurement inaccuracies and missing 
data. For example, one patient might have different ICD-9-CM codes entered for the 
same condition. In some cases less severe comorbidities such as diabetes, depression, 
angina or high blood pressure may be omitted from the record for critically ill patients; as 
a result, these conditions have been incorrectly associated with lower mortality odds in 
some studies [2]. Additionally, patients with good functional status and access to 
healthcare are more likely to have detailed health information recorded, while patients 
who are housebound, live in isolated rural areas, have cultural obstacles, or are 
otherwise disadvantaged are more likely to have incomplete records. Despite these 
sources of potential bias, a large body of previous work has shown that meaningful 








4.  Second Manuscript: Improved Comorbidity Summary Score for Measuring Disease 
Burden and Predicting Outcomes with Applications to Three National Cohorts  
 
4.1.  Introduction 
 Research involving administrative healthcare data to study patient outcomes 
requires the investigator to carefully consider the patient’s comorbidities, or disease 
burden in order to reduce the potential for biased inferences. This paper focuses on 
developing an improved summary score using one of the most popular sources for 
comorbidity information, that encoded by the International Classification of Diseases 
(ICD), which, in the ICD-9-CM version, consists of more than 14,000 unique codes. Each 
patient may have hundreds of ICD codes recorded over many years, and a large 
database may contain thousands of unique codes. Summary measures based on 
dimension reduction have thus become very popular tools. In some cases, these 
measures consist of a collection of disease conditions that serve as independent 
predictors; the Elixhauser comorbidity index is perhaps the most well-known example     
[2]. Other measures consist of single scores, such as the Charlson comorbidity index    
[1]. Because the Charlson and Elixhauser indices are well known and have been widely 
applied, investigators frequently use them without consideration for whether other 
methods could better adjust for disease burden. 
 ICD codes are primarily recorded for billing purposes, which can introduce 





found to be under-reported when ICD codes are compared to the patient’s clinical record 
[1, 63, 64]. Further, some chronic conditions such as high blood pressure or obesity are 
more likely to be recorded for patients who are generally fit, but more likely to be omitted 
for patients who are critically ill. Investigators have shown how this can lead to the false 
conclusion that some chronic conditions are associated with lower mortality odds [2]. 
This observation supported a hypothesis examined in this paper that gains in ICD 
summary measure performance might be made by including codes in prediction models 
that are associated with survival even when the clinical evidence suggests such codes 
may actually be associated with mortality. 
 The Charlson and Elixhauser indices were developed by different approaches, 
and were initially used to predict different outcomes. Charlson et al. [1] collected the 
comorbidities observed in 607 patients with hospital admissions during one month in 
1984; these patients were then followed for one year. She used those baseline 
comorbidities to predict time to death over the one year period using Cox proportional 
hazards models. The relative magnitudes of the estimated coefficients were used to 
develop a weighted score that was validated in a population of 685 breast cancer 
patients. Elixhauser later noted that the Charlson score was soon repurposed by other 
investigators to predict numerous events other than one-year mortality, including short-
term outcomes such as in-hospital mortality, hospital charges or length of stay. She was 
also concerned that the range of Charlson comorbidities was limited by the small 
population used to develop the score. Elixhauser et al. [2] instead considered the full 
range of conditions included in the ICD-9-CM coding manual as well as the comorbidities 





term hospitalization outcomes, and used a narrow comorbidity definition that excluded 
conditions related to the primary reason for hospitalization, problems that might be 
complications that arose during treatment, or conditions she considered unimportant. To 
assess which conditions were most predictive, she conducted ordinary least squares 
regression or logistic regression to predict hospitalization charges, length of stay, or in-
hospital mortality. She proposed an index of 31 independent comorbidities, and 
deliberately avoided combining them into a single score because she considered each 
investigator should examine the independent contributions of comorbidities where 
possible. Her index did not include numerous serious conditions that were not strongly 
associated with her short-term hospitalization outcomes; examples include dementia, 
Alzheimer’s disease, or some types of renal disease. She reported that by excluding any 
condition that could be considered a complication of treatment, her index was less 
successful in predicting mortality than her other short-term outcomes. Such excluded 
conditions included pneumonia, cardiac arrest, cardiogenic shock, and respiratory failure 
[2]. 
  The Elixhauser index has subsequently been applied to a wide range of 
outcomes, in some cases with little apparent regard for the reasoning behind the index’s 
construction. For example, Baldwin et al. [65] used the Elixhauser index in models to 
predict two-year non-cancer mortality and the receipt of chemotherapy in cancer 
patients; Chu et al. [10] used it to predict one-year mortality; Lix et al. [66] used it to 
predict amputation, end stage renal disease, and stroke in diabetes patients. Since the 





short-term hospitalization outcomes or associated with treatment complications, the 
index may be less effective in predicting these other outcomes.  
 Both the Charlson and Elixhauser indices were developed using simple 
regression and proportional hazards models, and both involved arbitrary inclusion or 
exclusion of specific conditions rather than relying on strictly empirical methods to 
determine which predictors were most important. Since their development, numerous 
advances in statistical methods, machine learning algorithms, and computational power 
have occurred. In the first manuscript, a number of machine learning and statistical 
classification methods were compared to demonstrate that substantial improvements in 
prediction performance over existing indices could be achieved to predict five-year 
mortality.   The most effective of these methods included Bayesian Additive Regression 
Trees (BART), Random Forest (RF), and elastic-net penalized generalized linear 
models. However, such models included up to 1000 predictors and could be 
cumbersome to apply in some areas of research. Here the goal is to instead develop a 
simple comorbidity summary score based on the insights gained in the previous work 
and show it has superior predictive performance to the Quan version of the Elixhauser 
index [9] when used to predict five-year mortality. The Elixhauser index is used as the 
basis for comparison because it was shown to have better predictive performance than 
the Charlson Index; the Quan version is used because of its improved performance over 
earlier versions of the Elixhauser Index [9]. The ICD-9-CM is included here rather than 
the ICD-10-CM system because the Veteran’s Administration data used here was 
recorded under the older ICD-9 system, though the same methods could easily be 






4.2.  Study Design and Methods 
4.2.1 Study Populations 
Three national cohorts of U.S. Veterans were used in this work; these had been 
created for earlier studies by linking numerous Veterans Health Administration patient 
and administrative databases. The first included 625,903 patients with diabetes mellitus 
(DM) based on two or more related ICD-9-CM codes and at least one prescription filled 
for a medication to treat diabetes [47]. In the original study, Veterans were followed from 
2002 until death, loss to follow-up, or until December 2006, and newer data was added 
here to extend the follow-time until December 2012. The second cohort involved 
168,125 Veterans diagnosed with traumatic brain injury (TBI) during 2004 and 2005. In 
the original study, patients were followed from the point of entry until death, loss to 
follow-up, or until December 2010 [48]; newer data was added to extend the follow-time 
to December 2012. The third cohort involved 3,359,560 patients with chronic kidney 
disease (CKD) defined for stages 1 through 5 based on estimated glomerular filtration 
rates calculated from serum creatinine levels and the patient’s age, gender, and race. 
CKD patients were also identified through ICD-9-CM codes. CKD patients were followed 
from 2000 until December 2012, loss to follow-up, or until death. Kidney or liver 
transplant recipients were excluded (M. N. Ozieh, M. Gebregziabher, R. Ward, D. J. 
Taber, L. Egede, unpublished data, 2016). All studies were approved by the Medical 
University of South Carolina Institutional Review Board (IRB) and the Ralph H. Johnson 






4.2.2 Covariates and outcome 
  The predictors in all models were binary variables, each based on a single ICD 
condition. No other predictors were included since it was demonstrated in the first 
manuscript that no additional insights into effective modeling of ICD data were obtained 
by including other patient covariates. The outcome for all models was five-year mortality. 
 
4.2.3 Methods 
 Figure 7 provides an overview of the index development steps. For each patient 
in the three disease cohorts, the available ICD-9-CM codes were collected from the 
earliest available data until one year prior to mortality or through the end of the study if 
the patient did not die. Codes recorded within a year of death were excluded because 
conditions that often occur in this period (such as palliative care) might provide an 
unrealistic advantage against the Elixhauser models but would provide little help in 
making long-term predictions. An early cutoff for starting ICD collection was not 
established; instead all available codes were used for each patient. The challenge for 
the competing models was similar to asking, “given all of the patient’s ICD codes up until 
today, predict whether he or she will die in the next five years.” Although patients varied 
by the length of available ICD code history, this was considered this was an expected 
condition in chronic disease cohorts, and results were compared to those from 






Figure 7: Overview of summary score development. 
 
 Prior to analysis, erroneous duplicate formats of ICD-9 codes were identified and 
corrected to the single correct format. For example, codes 250, 2500, and 25000 all 
represent the same condition, but each would be treated as separate predictors in 
machine learning algorithms. Out of the approximately 14,000 unique ICD-9 codes, the 
1000 most prevalent codes for each cohort were retained, and then those codes that 
were not common to all cohorts were excluded. There were 814 such codes, which 
formed the common set of binary predictors, where a ‘1’ indicated the given ICD-9-CM 





Four types of training and validation data sets were generated; three were drawn 
from the DM, CKD and TBI cohorts, and the fourth was a combined cohort created by 
sampling in approximately equal proportions from the three disease cohorts. Use of the 
combined cohort was intended to show how well the index might function in a more 
general population. 
Resampling methods were used due to concerns for computational efficiency 
with the machine learning methods, for which is could be difficult or impossible to 
complete an analysis of the entire dataset without use of a parallel computing 
environment. Smaller test and training datasets were generated, each with 5000 
observations, by randomly sampling the full datasets 1000 times with replacement. 
Performance statistics were collected for each validation run and the overall mean and 
95% confidence intervals generated by 1000 iterations were used to compare the 
models’ relative performance. As demonstrated by Marshall et al. [37] and 
Gebregziabher et al. [49], this non-parametric bootstrapping approach is reasonable for 
our large datasets, such that independence between numerous samples is reasonably 
assured. 
4.2.3.1 Prediction Models 
The top-performing methods from the first manuscript: random forest (RF), 
Bayesian additive regression trees (BART) and elastic-net penalized regression (REG), 
are again used here to provide variable importance measures for use in summary score 
development. The machine learning methods (RF and BART) are capable of 





exist in these data. Elastic-net penalized regression provides an efficient way to handle 
possible collinearities between predictors, while shrinking the estimated coefficients of 
less important predictors. Each method is used to develop separate estimates of 
variable importance for use in index development. 
 Random forest [28] is an ensemble method based on classification trees that is 
often effective in datasets with many weak predictors, as is the case with ICD-9 data. It 
relies on bootstrap aggregation (or ‘bagging’) to generate a forest, which is termed 
“random” due to the random selection of a pre-specified number of features (or predictor 
variables) at each tree’s nodes. The feature that leads to the largest improvement in the 
tree’s classification ability is then used to split the data at that node. The random forest 
method can automatically account for complex interactions, and was reported to be very 
competitive with other machine learning methods when compared on the basis of 
misclassification error [14]. Each variable’s mean decrease in the Gini Index is used as a 
measure of variable importance for use in model development. For  observations at 
node m, for outcome variable y with class levels k, and with predictors  , the 
proportion of observations at a node for a given predictor and class level k is 
. 
The Gini Index at this node is given by [14] : 
. 
Large changes in the Gini index at a given node indicate the splitting variable’s 























predictor across all trees and across 1000 iterations is used as the variable importance 
measure. These values are always positive, regardless of whether a predictor is 
associated with survival or mortality. The R package randomForest is used to implement 
this method [58] . 
 Bayesian Additive Regression Trees (BART) [60] is an extension of the 
supervised tree-based ensemble learning method, but unlike random forest, prior 
distributions are established for each tree’s decision rules and terminal node 
parameters, and an MCMC algorithm is used to sample from the posterior distribution for 
the ensemble of trees. The authors contend their approach provides a substantial 
degree of regularization such that each tree’s complexity is reduced. Predictive results 
reported in some datasets were superior to random forest, neural nets, and regularized 
regression methods [60].  
 The R package BayesTree was used to implement BART [59]. This algorithm 
develops the model based on the training data, and then provides the results of post-
convergence samples from the posterior distribution using test data. Variable importance 
is estimated by the mean count of how many times each predictor is selected for use in 
a node’s decision rule among all trees over all MCMC samples and over all 1000 
iterations. These values are always positive. 
 Elastic-net regression, which involves the use of a regularized generalized linear 
model, provided another measure of variable importance. In the work supporting the first 
manuscript a number of regularized regression methods were compared, including ridge 





regression [53], and found that elastic-net regression provided the best predictive 
performance in the ICD code data. The elastic-net model combines the LASSO and 
ridge approaches with the addition of parameter  such that the loss function becomes 
the LASSO model for , and the ridge model when . For binary outcome
, predictors  and shrinkage parameter , the following 
equation is minimized in order to determine coefficient estimates:   
. 
= 0.5 provided the best predictive performance. The R package glmnet [54] was used 
to implement this method, and used the mean coefficient estimates from 1000 iterations 
as variable importance measures. The sign of the mean coefficient estimates were used 
to weight the index by  based on the association with survival or mortality, as 
discussed further below. 
4.2.3.2 Score algorithm: 
 When analyses were completed on the DM, TBI, CKD and combined datasets, 
there were 12 variable importance results from the RF, BART and REG models for each 
of the 814 ICD-9-CM predictors. The following algorithm was used to develop a 
summary score: 
 (1) Determine which predictors have variable importance measures ranked in the 
top 50% in all 12 results.  

1  0 
( 1,1)y 





























 (2) For such predictors and the patient, establish , 
, to signify which predictors are recorded in a given patient’s record. 
 (2) Determine whether each predictor is associated with mortality or survival 
based on whether the majority of elastic-net estimated parameters from the four 
datasets are positive or negative; in the rare case of a tie assume a mortality 
association. Note that RF and BART variable importance measures are always positive 
regardless of the association.  
 (3) Assign weights  of +1 to those conditions associated with 
mortality and -1 to those associated with survival.  
 (4) Calculate a summary score for each patient: .  
 
4.2.4.3 Score assessment 
 The summary score was used as the single predictor in a logistic regression 
models using validation datasets from each of the four population groups. Its 
performance was compared to similar models based on the Elixhauser index using the 
area under the ROC curve (AUC), net reclassification improvement, Brier score [22], 
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75.0 73.1 49.9 
Five-year mortality (%) 
 
41.9 38.7 20.9 
Gender (%) male 96.7 97.0 93.7 
 
female 3.3 3.0 6.3 
Marital status (%) single 6.3 7.0 26.0 
 
widowed 14.8 11.0 4.6 
 
divorced 21.0 21.0 25.9 
 
married 58.0 59.0 42.1 
Race/ethnicity (%) Non-Hispanic white 81.4 76.0 55.8 
 
Non-Hispanic black 13.6 15.0 13.0 
 
Hispanic 2.9 5.0 1.9 
 
other or missing 2.2 4.0 29.2 
Homeless (%) 
 
6.3 8.0 1.5 
Greater than 50% 
disability (%) service-related 23.4 27.0 23.3 
 
4.3.  Results 
Table 5 provides a summary of demographic information for the three cohorts. 
Five-year mortality ranged between 20.9 and 41.9%. The TBI cohort’s mean age was  
49.9, while the other groups had mean ages of 75.0 and 73.1. The groups’ gender and 
racial-ethnic makeup is typical for Veteran populations with these age distributions. 
Between 23% and 27% of Veterans had at least 50% disability connected with their 
military service.  
 Figure 8 and Table 6 compare the performance of the summary score to the 

















Figure 8: Mean performance statistics with 95% confidence intervals based on 1000 iterations 
using validation datasets for the chronic kidney disease (CKD), traumatic brain injury (TBI), type 2 
diabetes mellitus (DM), and the combined cohort, which was formed by randomly drawing from 
the first three cohorts in equal proportions. AUC is the area under the receiver operator 
characteristic curve; NRI (event) and NRI (nonevent) are the net reclassification improvement 
statistics for mortality and survival. NRI values for the Elixhauser models are set at 0.00 since 
they serve as the reference. The outcome was five-year mortality. In each cohort, summary score 
models demonstrated significantly better predictive performance compared to models based on 
the 31 Elixhauser comorbidities.  
 
reclassification improvement, sensitivity, and specification statistics from models 
validated on each disease cohort and on a combined cohort. Mean AUC values for the 





Table 6: Mean performance statistics with 95% confidence intervals based on 1000 iterations 
using validation datasets for the chronic kidney disease (CKD), traumatic brain injury (TBI), type 2 
diabetes mellitus (DM), and the combined cohort, which was formed by randomly drawing from 
the first three cohorts in equal proportions. AUC is the area under the receiver operator 
characteristic curve; NRI (event) and NRI (nonevent) are the net reclassification improvement 
statistics for mortality and survival. NRI values for the Elixhauser models are set at 0.00 since 
they serve as the reference. The outcome was five-year mortality. In each cohort, summary score 
models demonstrated significantly better predictive performance compared to models based on 
the 31 Elixhauser comorbidities. 







AUC  0.72 (0.70;  0.73)   0.81 (0.80;  0.82)   0.78 (0.77;  0.80)   0.84 (0.83;  0.85)  
Sensitivity  0.46 (0.42;  0.50)   0.66 (0.64;  0.68)   0.24 (0.20;  0.29)   0.39 (0.35;  0.49)  
Specificity  0.82 (0.80;  0.84)   0.81 (0.79;  0.82)   0.96 (0.95;  0.96)   0.97 (0.95;  0.97)  
NR(event) ref  0.20 (0.16;  0.24)  ref  0.15 (0.10;  0.24)  
NRI(nonevent) ref -0.02 (-0.04;  0.01)  ref  0.01 (0.00;  0.02)  
Brier Score  0.21 (0.20;  0.21)   0.17 (0.17;  0.18)   0.14 (0.13;  0.14)   0.11 (0.11;  0.12)  







AUC  0.72 (0.71;  0.74)   0.84 (0.83;  0.85)   0.74 (0.73;  0.75)   0.84 (0.82;  0.85)  
Sensitivity  0.41 (0.36;  0.45)   0.69 (0.61;  0.71)   0.36 (0.32;  0.40)   0.60 (0.51;  0.64)  
Specificity  0.86 (0.84;  0.89)   0.83 (0.82;  0.86)   0.89 (0.88;  0.91)   0.88 (0.86;  0.92)  
NR(event) ref  0.28 (0.22;  0.33)  ref  0.24 (0.15;  0.29)  
NRI(nonevent) ref  -0.03 (-0.06;  0.00)  ref  -0.01 (-0.03;  0.02)  
Brier Score  0.20 (0.20;  0.21)   0.16 (0.15;  0.16)   0.19 (0.18;  0.19)   0.15 (0.15;  0.16)  
 
the Elixhauser index. Brier score values were consistent with the AUC results. Mean 
sensitivity values for the new score ranged between 0.39 – 0.69, compared to 0.24 – 
0.46 for the Elixhauser index. Mean specificity values for the score ranged between 0.81 
– 0.97, compared to 0.82 – 0.96 for the Elixhauser models. Mean net reclassification 
improvement (NRI) statistics for predicting mortality or survival were consistent with the 





 Table 7 (following the Discussion section) lists the ICD-9-CM codes used to 
predict five-year mortality in the summary score, and indicates whether each code is 
included in the Elixhauser index’s definition. Overall, 97 of the 121 codes in the index 
were not part of the Elixhauser index definition, and 63 of the 121 codes are associated 
with mortality. 
 
4.4.  Discussion  
 This work produced a comorbidity summary score for predicting five-year 
mortality that had stronger predictive performance than the widely-used Elixhauser 
index. The models used in the score’s development were trained and validated on three 
large Veterans Administration datasets and further validation was based on a combined 
cohort, which provided a broad range of comorbidities and disease severity levels. The 
score was comprised of ICD-9 codes with variable importance measures that fell in the 
top 50% of all twelve model runs (four training datasets and three classification 
methods). Strong improvements in predictive performance were demonstrated based on 
AUC and Brier Score statistics. There were also some improvements in sensitivity and 
net reclassification improvement for mortality when compared to the Elixhauser index, 
while specificity values remained generally the same. The score’s strong performance in 
the combined cohort provided some initial evidence that it could be successfully applied 
to a more general population, but further work is needed to demonstrate this. 





  (1) First, 58 of 121 conditions were negatively weighted since they were 
associated with survival in the models, and many patients had an overall negative score. 
As hypothesized, by including codes statistically associated with survival, model 
predictive performance improved, even when the clinical evidence suggests such codes 
in some cases may actually be associated with mortality. Such codes may be recorded 
in healthier patients who are not being treated for more serious conditions (obesity or 
hyperlipidemia for example); other codes in this category simply recorded routine 
outpatient visits (routine screening or exam codes). The models predicted that patients 
with large numbers of these negatively weighted conditions and few of the more serious 
illnesses are more likely to survive.  
 (2) Next, the summary score is simpler to implement since it consists of only 121 
ICD-9 codes, compared to more than 1000 unique codes in the Elixhauser index 
definition.  
 (3) While the Elixhauser index definition excluded conditions not associated with 
short-term hospitalization outcomes and any acute conditions considered treatment 
complications, all such conditions that occurred at least one year prior to death were 
considered since they could be valid mortality predictors. This approach is more suitable 
for the long-term outcome was considered here. Examples of acute conditions included 
in the summary score but excluded in the Elixhauser index include pneumonia and acute 
cerebrovascular disease. 
 (4) The summary score contained a number of conditions related to the patient’s 





disease, senile dementia, hearing loss, persistent mental disorders, memory loss, falls, 
no other household member able to render care, and urinary incontinence.  
 Several conditions in the summary score may have unexpected associations with 
mortality, and warrant further discussion. For example, nail dermatophytosis, or nail 
fungal infection, might generally be considered a benign condition, but Scher et al. [67] 
and Loo [68] report its prevalence rises both with age and the presence of peripheral 
vascular disease and diabetes. This may explain its predictive importance in these 
Veteran populations. In another example, the code ‘V048: need for prophylactic 
vaccination against other viral diseases’ might also be considered to be benign, but 
further investigation showed this code may be a proxy for age since its use was 
discontinued in 2003 when it was replaced by a number of other codes [69].  
  The new comorbidity measure is not intended to provide a comprehensive 
clinical summary of a patient’s disease burden; instead, it provides a simple prediction of 
five-year mortality based on a comparison with millions of other Veterans for whether a 
the patient has specific conditions that were most predictive in this population.   
 Although summary scores are convenient tools, investigators should apply them 
with care. As Elixhauser et al. noted [2], combining individual predictors into a single 
index may lead to a loss of explanatory power. Romano et al. [8] commented that 
summary indices might be most appropriate in small datasets where it is not feasible to 
model a large group of comorbidities. They also warned that investigators should not 
apply an index without carefully considering the assumptions and outcomes used in its 





Scneeweiss et al. [70] further cautioned that the weights developed for one population 
are not likely to be generalizable to other groups. Although the new score was 
developed using three large datasets involving different disease cohorts with a wide 
variety of comorbidities, these populations are generally limited to older male Veterans, 
and further work is needed to determine the score’s predictive performance in a wider 
population. As Scneewiess et al. [70] wrote, a summary score might be most suitable for 
use as a convenient data exploration tool to rapidly assess large ICD code datasets. In 
general, investigators working with such data may be most successful by developing 
dedicated comorbidity models for their unique populations and outcomes using the 






Table 7: ICD-9-CM conditions that form the summary score, ordered by ICD hierarchy. Those 
conditions contained in the Elixhauser index definition [9] are indicated by a “+” symbol. 
Conditions associated with mortality have an index weight of +1; those associated with survival 
have weights of -1. 97 of the 121 codes in the index were not part of the Elixhauser index 
definition, and 63 of the 121 codes are associated with mortality. Many of those conditions not 












  1 1101 Dermatophytosis of nail 
+ 1 1629 Malignant neoplasm of bronchus and lung, unspecified 
  1 1733 Unspecified malignant neoplasm of skin, unspecified parts of face 
  1 1739 Other malignant neoplasm of skin 
+ 1 185 Malignant neoplasm of prostate 
+ 1 25000 Diabetes mellitus without mention of complication 
+ 1 25001 Type I Diabetes mellitus  
+ 1 25060 Diabetes with neurological manifestations 
  -1 2722 Mixed hyperlipidemia 
  -1 2724 Other and unspecified hyperlipidemia 
+ 1 2765 Volume depletion disorder 
+ 1 2767 Hyperpotassemia 
+ -1 27800 Obesity, unspecified 
+ 1 2809 Iron deficiency anemia, unspecified 
+ 1 2859 Anemia, unspecified 
+ 1 2875 Thrombocytopenia, unspecified 
  1 2900 Senile dementia, uncomplicated 
  1 2948 Other persistent mental disorders  
  1 2949 Unspecified persistent mental disorders  
+ 1 2989 Unspecified psychosis 
  -1 30272 Psychosexual dysfunction  
  -1 32723 Obstructive sleep apnea  
  1 3310 Alzheimer's disease 
+ 1 3320 Parkinson’s disease 
  -1 33829 Other chronic pain 
  -1 3540 Carpal tunnel syndrome 
  1 36201 Background diabetic retinopathy 
  1 36250 Macular degeneration (senile), unspecified 
  1 36251 Nonexudative senile macular degeneration 
  -1 36501 Open angle glaucoma with borderline findings, low risk 



















 -1 3671 Myopia 
 -1 38830 Tinnitus, unspecified 
 -1 38831 Subjective tinnitus 
 1 38910 Sensorineural hearing loss, unspecified 
 1 3892  Mixed conductive and sensorineural hearing loss 
+ 1 40391 Hypertensive chronic kidney disease with end stage renal disease 
 1 41400 Coronary atherosclerosis  
+ 1 4241 Aortic valve disorders 
+ 1 42731 Atrial fibrillation 
+ 1 4280 Congestive heart failure, unspecified 
 1 436 Acute, but ill-defined, cerebrovascular disease 
 1 4389 Unspecified late effects of cerebrovascular disease 
+ 1 4439 Peripheral vascular disease, unspecified 
 
1 4538 Acute venous embolism and thrombosis of other specified veins 
 
1 45981 Venous (peripheral) insufficiency, unspecified 
 
-1 4619 Acute sinusitis, unspecified 
 
-1 462 Acute pharyngitis 
 
-1 4659 Acute upper respiratory infections of unspecified site 
 
-1 4739 Unspecified sinusitis (chronic) 
 
-1 4779 Allergic rhinitis, cause unspecified 
 
1 486 Pneumonia, organism unspecified 
+ 1 49121 Obstructive chronic bronchitis with (acute) exacerbation 
+ 1 4928 Other emphysema 
+ -1 49390 Asthma, unspecified type, unspecified 
+ 1 496 Chronic airway obstruction 
 
1 51889 Other diseases of lung, not elsewhere classified 
 
-1 52102 Dental caries extending into dentine 
 
-1 52103 Dental caries extending into pulp 
+ 1 5715 Cirrhosis of liver without mention of alcohol 
 
1 5789 Hemorrhage of gastrointestinal tract, unspecified 
+ 1 585 Chronic kidney disease 
 
-1 5920 Calculus of kidney 
 
1 5939 Unspecified disorder of kidney and ureter 
 
1 5990 Urinary tract infection 
 
1 5997 Hematuria 
 
1 7051 Acute hepatitis C without mention of hepatic coma 
 
-1 71536 Osteoarthrosis, localized, lower leg 
 
-1 71941 Pain in joint, shoulder region 
 
-1 71944 Pain in joint, hand 
 
-1 71946 Pain in joint, lower leg 
 

















  -1 7231 Cervicalgia 
  -1 7242 Lumbago 
  -1 7243 Sciatica 
  -1 72690 Enthesopathy of unspecified site 
  -1 72871 Plantar fascial fibromatosis 
  1 73300 Osteoporosis, unspecified 
  -1 78057 Unspecified sleep apnea 
  1 78097 Altered mental status 
  1 7812 Abnormality of gait 
  -1 7820 Disturbance of skin sensation 
  1 7823 Edema 
  1 78321 Loss of weight 
  -1 7840 Headache 
  -1 78659 Other chest pain 
  1 78820 Retention of urine, unspecified 
  1 78830 Urinary incontinence, unspecified 
  -1 79021 Impaired fasting glucose 
  -1 79029 Other abnormal glucose 
  1 7931 
Abnormal findings on radiological /other examination of lung 
field 
  -1 7962 
Elevated blood pressure reading without diagnosis of 
hypertension 
  1 7993 Debility, unspecified 
  -1 9953 Allergy, unspecified, not elsewhere classified 
  1 E8889 Unspecified fall 
  -1 V0382 Other vaccinations against streptococcus pneumoniae  
  1 V048 Need for prophylactic vaccination, other viral diseases 
  -1 V0481 
Need for prophylactic vaccination and inoculation against 
influenza 
  -1 V065 Need for prophylactic vaccination against tetanus-diphtheria 
  -1 V1272 Personal history of colonic polyps 
  1 V431 Lens replaced by other means 
  -1 V531 Fitting and adjustment of spectacles and contact lenses 
  1 V583 Attention to dressings and sutures 
  1 V5861 Long-term (current) use of anticoagulants 
  -1 V5883 Encounter for therapeutic drug monitoring 
  1 V604 No other household member able to render care 
  -1 V653 Dietary surveillance and counseling 
  -1 V6540 Counseling NOS 
  -1 V6549 Other specified counseling 
















  -1 V6801 Disability examination 
  1 V681 Issue of repeat prescriptions 
  -1 V700 Routine general medical examination at a health care facility 
  -1 V703 Other general medical examination for administrative purposes 
  -1 V705 Health examination of defined subpopulations 
  -1 V7189 
Observation and evaluation for other specified suspected 
conditions 
  -1 V7260 Laboratory examination, unspecified 
  -1 V7651 Special screening for malignant neoplasms of colon 
  -1 V802 Screening for other eye conditions 
  -1 V812 Screening for other and unspecified cardiovascular conditions 








5.  Third Manuscript: Comprehensive Comparison of Machine Learning and Model-





 Missing data is a frequent problem in administrative healthcare databases, and 
investigators working with such data must carefully assess how to best approach this 
problem in order to reduce the possibility for biased results. In Veterans Health 
Administration (VHA) research to investigate the reasons for health inequities among 
minority groups, missing data in key variables such as patient race and ethnicity can 
pose tremendous challenges. In past years, researchers often dealt with the missing 
data problem by simply conducting complete-case analysis, though this strategy could 
lead to biased results unless the data were missing completely at random. More 
recently, steps to attempt to assess the pattern of missingness and methods to help 
achieve unbiased results such as multiple imputation are commonly seen.  
 When assessing missing data, it is important to determine what type of 
relationship exists between the missing values and the mechanism that led to their being 
missing. Three such scenarios are typically defined [71]: 
a. Missing completely at random (MCAR): in this situation, the probability of missing 
values does not depend on either the observed or the missing values. 
b. Missing at random (MAR): In this case, the probability of missing values depends 





c. Missing not at random (MNAR): in this case, the probability of missing values 
occurring depends on unobserved observations. The MNAR pattern cannot be 
ruled out by examining the data since it exists due to information not contained in 
the data, and investigators who rely on imputation methods that rely on MAR or 
MCAR assumptions should take additional steps to assess whether their results 
are sensitive to changes under MNAR conditions. 
 Numerous parametric imputation methods exist for handling data with MCAR or 
MAR patterns; multiple imputation by chained equations (MICE) is one commonly used 
approach due to its ability to handle multiple imputation for mixed data types [25, 26]. 
MICE imputes missing values from separate distributions for each variable with missing 
values conditional on the other variables, but has been criticized for lacking a theoretical 
basis [27], and for requiring the investigator to have advance knowledge of non-linear 
relationships or collinearities between predictors [17]. Other researchers have concluded 
that machine learning methods can automatically handle interactions and other concerns 
while also producing inference estimates with narrower confidence limits and with more 
computational efficiency. The random forest algorithm has been applied in several 
multiple imputation research efforts, and involves bootstrap aggregation of numerous 
independent decision trees, and can account for complex interactions and collinearities 
between predictors more readily than many parametric methods, while the ensemble 
voting of independent trees naturally lends itself to an efficient imputation process [28]. 
For example Stekhoven et al. [16] claim their multiple imputation approach (missForest) 
based on the random forest method was superior to traditional statistical methods 





mean squared errors. Jerez et al. [29] provided a similar conclusion based on a 
comparison of machine learning and statistical imputation methods.  Other researchers 
have incorporated machine learning methods within an existing statistical method; for 
example, Shah et al [17] incorporated random forest as the multiple imputation method 
within the existing MICE method and showed the new approach had a superior ability to 
handle nonlinear relationships and collinearities.  
 Though the multiple imputation methods described above are capable of 
producing unbiased results under MCAR and MAR, such results are far less likely when 
a missing not at random (MNAR) condition exists. As Verbeke et al. [30] discuss, it is 
possible to construct models based on MNAR assumptions, but these assumptions are 
not testable since their support is not contained in the data. Further, Molenburghs et al. 
[31] demonstrated that it is not possible to empirically distinguish between MNAR and 
MAR situations from the data alone because for every MNAR model, it is possible to 
build an MAR model with the same fit. The most common approach given these 
circumstances is to conduct sensitivity analysis on MAR models to examine their stability 
when MNAR assumptions are introduced [32, 33]. Though numerous approaches are 
possible, two general types of sensitivity analyses are most common; these are based 
on pattern mixture models [32 – 34] and selection models [35].  
 
5.1.1  Motivating Example  
 This research involves a VHA cohort of 161,586 Veterans treated for traumatic 
brain injury (TBI) between 2004 and 2010. In the original study, patients were followed 





data was merged to extend the follow-time to December 2012. The study was approved 
by the Medical University of South Carolina Institutional Review Board (IRB) and the 
Ralph H. Johnson Veterans Affairs Medical Center Research and Development 
committee. 
  The original dataset had approximately 30% missing race-ethnicity, which was 
derived solely from VHA Corporate Data Warehouse (CDW) MedSAS files. The missing 
proportion was reduced to 2% by merging newer information from the CDW 
PatSub_PatientRace and Pat_Sub_PatientEthnicity tables, followed by Medicare race-
ethnicity information from the VitalStatus table. Table 8 provides the demographic and 
clinical characteristics for this group, and Table 9 provides a comparison of the original 
and updated race distributions. The newer race distribution appears to be more typical of 
the VA population, and the combined effects of better race-ethnicity data collection [24] 
and the use of Medicare data [23] provide solid support for the claim that the newer 
distribution is more accurate. The updated race distribution provided strong evidence 
that an MNAR pattern existed in the original data. It was then possible to compare the 
results of several multiple imputation methods using the original data against results 
obtained by using the updated race distribution. Since the motivating example involves 
MNAR missingness, this research also involved applying several types of sensitivity 
analyses to determine if such approaches provide any additional insights. 
 Consistent with the problems seen in the TBI cohort, several investigators have 
reported the absence of race information in VHA or Medicare data may be due to non-
random causes [4 – 6]. Depending on the timeframe being studied, the level of 





VHA patient records had missing race-ethnicity information in 2004, but this value had 
been reduced to 15% by 2012 [3] due to concerted efforts to collect this information and 
due to a 2003 requirement for recording self-reported race-ethnicity rather than 
observer-reported values [24]. Stroupe et al. [23] demonstrated that further 
improvements were possible by merging VHA data with Medicare data; in the author’s 
experience with several VHA cohorts followed through 2012 or later, the missing race 
fraction can be reduced below 3% in some cases.    
 This research provides a unique contribution by conducting a comprehensive 
comparison of multiple imputation (MI) methods under both MAR and MNAR conditions 
using approaches that incorporate both machine learning and statistical methods. 
Additionally, for missing race/ethnicity variables under MNAR, it examines the 
effectiveness of several types of sensitivity analyses, both in simulations and in real data 
application. The remainder of this aim is organized as follows: the Methods section 
provides a description of the multiple imputation methods and sensitivity analyses that 
are applied here, first in a simulation, and then in the TBI example. The simulation 
framework is then described, including how MCAR, MAR and MNAR patterns are 
generated in the simulation data. In the Results and Discussion sections the insights 
gained from this work are reviewed, particularly that MNAR missingness is an extremely 
challenging problem, even when the data’s MNAR mechanism is well understood. 
 
5.2. Methods 
 Multiple imputation (MI) is a common approach for handling missing data. Rubin 





numerous single imputation methods, particularly that MI is far more capable of 
modeling the uncertainty associated with each imputed value, especially when the 
reason for value being missing is unknown. Van Buuren et al. [26] discussed the 
challenges for applying MI to multivariate data, where many predictors can have missing 
values, and described two general approaches:  
a. Joint modeling, where a joint parametric multivariate distribution is specified, and 
imputations are generated in a Bayesian framework from the posterior predictive 
distribution. However, this approach requires the analyst to fully specify the model, 
such that any unknown interaction or nonlinearity may lead to biased results.  
b. Fully conditional specification models (FCS), or Multiple Imputation by Chained 
Equations (MICE): here each predictor has a distribution conditional on all of the 
other predictors, with distribution parameters specific to each predictor rather than 
associated with a joint distribution. This provides the important advantage of being 
able to easily handle continuous and categorical data types since each predictor has 
its own conditional distribution [26].  In MICE models, if Y  is a matrix for n patients 
and k predictors, and a portion of each predictor is missing: 
obs
jy  are the observed observations for the jth predictor, 
mis
jy are the missing observations for the jth predictor, and 
 jy  is defined as all of the predictors except the jth predictor. 
For ( | , )j j jP Y Y  , where j is the vector of parameters for the jth conditional 
distribution, each of the k parameters and predictors is successively sampled via a 
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M sampling processes are conducted in parallel, where M is typically 5 or 10, and 
each is continued for enough iterations to ensure convergence, typically less than 20 




































  where jB  is the variance of the parameter estimates.  
1(1 )*j j jT U M B
    where T is the total pooled variance for the 
thj  pooled 
parameter. 
 
5.2.1 MICE methods 
 Numerous imputation methods can be applied within the MICE framework, 
including traditional statistical methods and machine learning algorithms. The MICE 
package in R [72] was used to implement this framework, and separate functions were 
written to incorporate the BART and neural net methods. The R program code 






5.2.1.1 MICE with logistic regression and predictive mean matching (MICE-LR) 
 Here, logistic regression and predictive mean matching [73] are used to form the 
predictive conditional distributions for missing categorical and continuous variables. The 
goal was to compare these traditional methods with the machine learning approaches 
described below. 
 
5.2.1.2 MICE with random forest (MICE-RF)  
 Here the random forest algorithm [28] is used during each imputation to generate 
a selected number of trees based on observed data, each of which is used to make a 
prediction. The imputed value is randomly selected from these predictions.  
 
5.2.1.3 MICE with Bayesian Additive Regression Trees (MICE-BART) 
 BART [59] is an extension of the supervised tree-based ensemble learning 
method, but unlike random forest, prior distributions are established for each tree’s 
decision rules and terminal node parameters, and an MCMC algorithm is used to sample 
from the posterior distribution for the ensemble of trees. The R packages BayesTree [60]        
and MPBART [74] were used to generate imputed values for continuous and categorical 
variables, respectively. A separate function was developed here to incorporate these 
methods within the MICE framework.  While this method produced reasonable results for 
several iterations of the simulation, it was too slow to be viable when used on a typical 







5.2.1.4 MICE with neural net (MICE-NNET) 
 Here, a single hidden layer neural network was used during each imputation step 
[14]. This machine learning approach is a non-linear statistical model that approximates 
more traditional classification and regression models. The R package nnet [75]  was 
used to implement this method, and the size and weight decay parameters were tuned 
using 10-fold cross validation with the caret package in R [76].  A separate function was 
developed to incorporate neural net imputations within the MICE framework. 
 
5.2.2 Random forest multiple imputation: 
 The random forest algorithm was applied as a multiple imputation method 
independent of the MICE framework using the missForest package in R [16]. This 
algorithm orders the predictors with missing values based on their increasing proportion 
of missing values, and then imputes each variable in turn by generating a random forest 
based on the observed values for the variable of interest and all corresponding 
observations from the other variables. This forest is then used to impute the missing 
values of the variable of interest. Once each variable has been imputed, the entire 
process is repeated until a stopping point is reached based on the difference between 
successive imputed datasets. 
 
5.2.3 MNAR sensitivity analyses 
 Several sensitivity analyses were compared; these involve imposing MNAR 
assumptions on multiple imputation models that are based on MAR assumptions. This 





covariate in the TBI example had an MNAR missingness mechanism. Each of these 
methods requires the investigator to make assumptions about the missingness pattern, 
though such assumptions are unverifiable from the data itself. The departure of MNAR 
sensitivity analysis results from the MAR results is an indication that the MAR 
assumption may not hold. 
 
5.2.3.1 Pattern mixture model adjustment [32]  
 A pattern mixture model assumes that a number of missingness patterns may 
exist, each with a separate joint distribution for the partially and fully observed variables. 
For patients 1i ,...,n  and covariates 1iY  and 2iY , assume 1iY  has missing values with 
indicator
iR , such that 0iR when 1iY is missing and 0iR otherwise. Under MNAR the 
joint distribution  is factored as , where the joint distribution of 
the partially and fully observed variables is conditional on the partially observed variable.  
 Since the MNAR distribution cannot be determined from the observed data, 
Carpenter and Kenward [32] suggest starting from the MAR scenario and then adjusting 
the model using MNAR assumptions in order to examine whether the MAR model is 
sensitive to such changes. For example, the race-ethnicity variable in the TBI data has 4 
levels, and a multinomial logistic model was used to impute the missing values under 
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k k kd  x'β , for 4k  and 4 0d , and where  and   are multinomial model 
parameters.  
  
 In order to test various MNAR assumptions, shift parameters 
k  are introduced 















Following the adjustment, we then examine how the model inference changes under the 
MNAR assumption. An iterative processes is used to determine the combination of shift 
parameters that best matches the MNAR assumptions. 
 Several other types of pattern mixture models are applied to MNAR sensitivity 
analysis. One group of such methods involves data with monotone missingness 
patterns, which are defined for variables 1,... py y , such that when jy  is missing for a 
given observation, then it is also missing for ky  with k j . Such observations are 
grouped based on their missingness patterns, and specific groups are then used to 
impute a given variable. Two such methods were attempted here; the first is termed 
complete case missing values (CCMV), in which only observations with no missing 
values are used [73]. The second is neighboring case missing value (NCMV), where, for 
imputing values of jy , the closest group in the monotone hierarchy is used for imputation 







5.2.3.2 Parameter re-weighting  
 In this selection model approach described by Carpenter et al. [36], the estimated 
parameters determined from multiple imputation datasets generated under MAR 
assumptions are reweighted to reflect MNAR assumptions. This approximation requires 
that the MAR and MNAR distributions for these parameters overlap. 
The MNAR assumption is incorporated in a logistic model, 
1   i i ilogit(Pr( R )) 'X Y , 
where the outcome that patient i  has an observed value for covariate Y is related to iY
such that large positive values of   make the odds for observing Y  in this patient much 
higher, while large negative values have the opposite effect. Carpenter et al. [36] show 
that for m  imputations and 11i ,...,n  patients who are missing covariate Y , the weight 
for the 
















. The imputed results are 





ˆ ˆw  , where m̂ is the MAR parameter estimate for the 









  where U is the weighted mean of parameter estimate variances;
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   where B  is the between variance of the parameter estimates. 





While Carpenter et al. demonstrated this approach for continuous outcomes with MNAR 
missingness, Heraud-Bousquet et al. [78] provide additional insights for applying the   
weighting method to datasets with missing covariates, including categorical variables. 
 
5.2.1 Simulation Study 
 A simulation study was conducted in order to compare the multiple imputation 
methods described above against results from complete-case analysis under MCAR, 
MAR and MNAR scenarios. 1000 datasets with 5000 observations each were selected 
by randomly sampling with replacement from a Veterans Administration dataset that 
consisted of approximately 37,000 complete case observations from a diabetes cohort. 
Though it would have been possible to fully simulate such data, a resampling approach 
was used instead to help ensure that the complex structures and associations found in 
real patient observations were also present in the synthetic datasets. As demonstrated 
by Marshall et al. [37] and Gebregziabher et al. [38] this approach is reasonable when 
the original dataset is large enough to help assure independence between samples.  
 The outcome was mortality within the 10-year study timeframe, and covariates 
included demographic measures such as age (continuous variable), gender, racial-
ethnic group (non-Hispanic white, non-Hispanic black, Hispanic, other), marital status 
(married or single), and urban-rural location indicator. Clinical indicators included the 
percentage of disability connected to military service, the patient’s mean medication 
possession ratio (mean MPR), and the patient’s mean glycated hemoglobin (mean A1c) 
level during the study period. The variables with missingness imposed were racial-ethnic 





 MCAR, MAR and MNAR missingness scenarios were separately imposed on 
each bootstrapped dataset, and for each of these in turn, versions were generated with 
10%, 30%, or 50% missing values. Complete case analysis was conducted on each of 
these nine datasets, along with multiple imputation by the four methods discussed 
above.  Missing data patterns were generated by the following rules [79]: 
1) Missing Completely at Random (MCAR): missing observations for the racial-ethnic 
group, mean MPR, and mean A1c variables were determined on a completely 
random basis. 
2) Missing at Random by rank (MAR): when the patient died, the racial-ethnic group 
value was more likely to be missing; when the patient was single, the mean MPR 
variable was more likely to be missing; when the patient lived in a rural location, the 
mean A1c variable was more likely to be missing. 
3) Missing Not At Random (MNAR): when the patient was in the non-Hispanic black or 
Hispanic groups and died during the study window, the racial-ethnic value for that 
patient was more likely to be missing. When mean MPR or mean A1c were above 
their respective medians, each was more likely to be missing. 
  
 Once missing values were established using the rules described above, further 
adjustments were made on a random basis as needed to achieve the required total 
proportion of observations with any missing values. Finally, each dataset was tested 
using logistic regression to verify that the required missingness structure had been 
generated. Binary indicators were generated for each of the variables with missing 





outcomes in the three logistic regression models. For each type of missingness, the 
significance of the estimated parameters was evaluated, and a given dataset was 
accepted if odds ratios for the parameters of interest were at least 1.5. For example, in 
the MNAR case, predictors of interest were the non-Hispanic black and Hispanic groups, 
and mortality.  
 Imputation methods were compared using the following statistics: 
1) Relative bias: ˆ ˆ ˆ( ) /
o
    , where ̂  and ˆo are the generalized linear model 
parameter estimates based on the imputed data and the full dataset of 37,506 
complete cases, respectively. 
2) Efficiency: ˆ ˆvar( ) / var( )
o
    
3) Root mean square error: 
2 2ˆ ˆ ˆ( )o     , where 2̂ is the estimated variance of 
the parameter estimate from the model based on imputed data. 
4) Coverage probability: the probability based on 1000 bootstrapped iterations that the 







5.3  Results  
5.3.1 Simulation results:  
 Table 8 provides a summary of clinical and demographic characteristics for the 
diabetes (simulation) cohort. Figures 9 and 10 provide relative bias results for MAR and 
MNAR scenarios for those variables on which missingness was imposed: non-Hispanic 
black and Hispanic groups and for mean medication possession ratio (mean MPR) and 
mean glycated hemoglobin (mean A1c). Figure 11 provides coverage probability results. 
 When confidence intervals are compared in the MAR scenario, MICE with 
random forest imputation appeared to provide the least biased results when compared to 
complete case analysis, particularly at 50% missingness.  
 In the MNAR scenario, for the non-Hispanic black and Hispanic groups, all 
multiple imputation results were biased. However, for the two continuous variables, the 
MICE methods provided reasonable results. Coverage probability under MNAR is very 
poor for both race groups regardless of the MI method, but for mean MPR and mean 
A1C, coverage probability remains high. The missForest MI method appears to lag the 
other MI methods in coverage performance.   
 Figure 12 provides simulation results for MNAR sensitivity analyses, which were 
performed on multiple imputation results from data with 30% MNAR missingness in the 
non-Hispanic black and Hispanic groups. Under pattern mixture model 1 and selection 
model parameter weighting, shift parameters were iteratively adjusted to achieve the 




Table 8: Demographic and clinical characteristics of the diabetes (used in simulation) and the 





n = 37,506 
TBI 
Cohort 
n = 161,586 
Mean age (sd)      --- 73.4 (5.4) 49.9 (17.9) 
Mortality rate (%)      --- 45.6 23.9 
Gender (%) male 98.7 93.7 
Marital status (%) non-married2 28.2 57.9 
 
married 71.8 42.1 
Race/ethnicity (%)1 non-Hispanic white 80.9 55.9 
 
non-Hispanic black 9.9 13.0 
 
Hispanic 5.1 1.9 
 
other  4.0 2.6 
 missing --- 26.6 
Rural location (%)      --- 39.0 --- 
More than 50% service-
related disability (%)      --- 
 
7.3 23.3 
TBI severity less severe --- 22.7 
 moderate  --- 27.5 
 highest --- 49.8 
Mean HbA1c (mean/sd)3      --- 7.2 (1.1) --- 
Mean MPR (mean/sd)4      --- 0.79 (0.2) --- 
1  
original race-ethnicity distribution in TBI cohort 
2  
includes single, divorced, widowed, never married 
3 mean glycated hemoglobin 
4  
mean medication possession ratio (number of days of diabetes medication supply divided by 365 days (or if 
deceased during that year, the number of days until death) over the study period  
 
 
mixture model 2 (PMM-2), shift parameters were iteratively adjusted in order to provide 
the closest match in the imputed data with the true race distribution proportions for each 
group. While PMM-1 results did achieve low relative bias, the imputed datasets had 
substantially more non-Hispanic black and Hispanic members than seen in the original 
data. In PMM-2 on the other hand, when imputed datasets had approximately the same 
race distribution as in the original data, relative bias remained high. Bias was also high 





Table 9: comparison of original and updated race-ethnicity distributions for the traumatic brain 
injury (TBI) data. NHW is non-Hispanic white, NHB is non-Hispanic black. Under the original 
distribution, 26% of patients were classified as missing race-ethnicity information; under the 
newer distribution, which incorporated more recent VHA data sources and merged Medicare 
information, the percentage of missing values was reduced to approximately 2%. The new race 
distribution showed that race was likely missing under MNAR conditions in the original data (see 
table 10). 
 
 Original distribution 
   Updated 
Distribution NHW NHB Hispanic Other Missing Total (percent) 
NHW 83190 335 621 0 29562 113708 0.70 
NHB 478 19911 42 0 5795 26226 0.16 
Hispanic 5565 385 2339 0 4267 12556 0.08 
Other 1024 444 117 4231 0 5816 0.04 
Missing 0 0 0 0 3280 3280 0.02 
    
 
   Total 90257 21075 3119 4231 42904  161586 
 (percent) 0.56 0.13 0.02 0.03 0.27 
   
 
5.4.2 Results from TBI application: 
 The original and updated race and ethnicity distributions for the TBI group are 
shown in Table 9. By merging updated VHA and Medicare information, the proportion of 
missing values was reduced from about 26% to 2%. Of note, 34% of the Hispanic group 
in the updated distribution was in the missing category under the original distribution, 
compared with 26% and 22% for non-Hispanic whites and non-Hispanic blacks, 
respectively. Further, 47% of the Hispanic group had been misclassified to a different 





















Figure 9: Simulation results: relative bias with 95% confidence intervals for four multiple 
imputation methods compared to complete case analysis under MAR missingness. In this 
scenario, when the patient died, the racial-ethnic variable was more likely to be missing; when the 
patient was single, mean medication possession ratio (mean MPR) was more likely to be missing; 
when the patient lived in a rural location, the mean glycated hemoglobin (mean A1c) variable was 
more likely to be missing. Based on relative confidence intervals, MICE with random forest 
imputation appeared to provide the least biased results when compared to complete case 



















Figure 10: Simulation results: relative bias with 95% confidence intervals for four multiple 
imputation methods compared to complete case analysis under MNAR missingness. In this 
scenario, when the patient was in the non-Hispanic black or Hispanic groups and died during the 
study window, the racial-ethnic variable for that patient was more likely to be missing. When 
mean medication possession ratio (mean MPR) or mean glycated hemoglobin (mean A1c) were 
above their respective medians, each was more likely to be missing. For the non-Hispanic black 
and Hispanic groups, all of the multiple imputation results were biased. For the two continuous 




















Figure 11: Simulation results: coverage probability for each multiple imputation (MI) method and 
missingness scenario. For the non-Hispanic black and Hispanic groups, coverage probability 
under MNAR is very poor regardless of the MI method. For the continuous variables, coverage 
probability remains high under MNAR. The missForest MI method appears to lag the other MI 



















Figure 12: Simulation results for MNAR sensitivity adjustment: comparison of relative bias for 
three MNAR sensitivity analyses, all with 30% missingness. Sensitivity adjustments were made to 
multiple imputation results based on multinomial logistic regression models. These are compared 
with the unadjusted results (MAR imputation, in black) and with complete case analysis (light 
blue). Under pattern mixture model 1 and selection model parameter weighting, shift parameters 
were iteratively adjusted to achieve the lowest relative bias when compared against the true race 
distribution. Under pattern mixture model 2 (PMM-2), shift parameters were iteratively adjusted in 
order to provide the closest match in the imputed data with the true race distribution proportions 
for each group. While PMM-1 results were substantially improved, the imputed datasets had 
substantially more non-Hispanic black and Hispanic members than seen in the original data. In 
PMM-2, when imputed datasets had approximately the same race distribution as in the original 
data, relative bias remained high. The parameter reweighting analysis did not succeed because 







 Table 10 summarizes the association between missing race in the TBI data and  
other covariates. Of note, the association between the updated race-ethnicity variable 
and missing race in the original data shows indications of an MNAR pattern in the 
Hispanic group, with OR = 1.47 (95% CI, 1.41 - 1.52).  
 Table 11 compares the mortality odds ratios based on the updated race-ethnicity 
variable with those for complete case analysis in the original data, multiple imputation 
results, and three MNAR sensitivity analyses. The complete case odds ratio for 
Hispanics is 1.22 (95% CI, 1.11 - 1.33) compared with non-Hispanic whites, while the 
OR based on the updated race information is protective: 0.73 (95% CI, 0.69 - 0.77). In 
the multiple imputation comparison, the MissForest results appear to be biased lower for 
all three race groups, while the other multiple imputation methods provided generally 
similar results, and none differed substantially from complete case analysis. In the first 
pattern mixture model analysis (PMM-1) and selection model parameter weighting, shift 
parameters were iteratively adjusted to achieve the lowest relative bias when compared 
against the updated race distribution. The PMM-1 Hispanic OR result was 0.85 (95% CI: 
0.82 – 0 .88), but the imputed data contained an average of 28% Hispanic patients, 
compared with the actual value of 8%. The parameter weighting Hispanic result was 
nearly identical to the complete case result.  Under PMM-2, shift parameters were 
iteratively adjusted in order to provide the closest match in the imputed data with the 
updated race distribution; here the Hispanic group OR was 1.04 (95% CI, 0.96 - 1.12), 








Table 10: Odds ratios for the association between missing race-ethnicity in the original TBI 
dataset and other covariates. The race-ethnicity predictor here is the updated, or “true” race 
determined with newer information. The strong association between the Hispanic group and 
missing race is strong evidence for an MNAR mechanism.  
 
 
Variable Level OR (95% CI) 
 
 
Age   1.00 (1.00, 1.00) 
 
 
Gender Female 1.08 (1.03; 1.13) 
 
 
Marital Status Married --- 
 
 
  Non-married 0.88 (0.86; 0.91) 
  Race-ethnicity1 NHW ---  
  NHB 0.91 (0.78; 0.83)  
  Hispanic 1.47 (1.41; 1.52)  
  Other2 0  
 
TBI severity less  --- 
 
 
  moderate 1.27 (1.23; 1.31) 
 
 
  most 1.34 (1.30; 1.39) 
 
 
Homeless   0.41 (0.36; 0.47) 
 
 









Using updated race-ethnicity distribution to predict missing values 
in older race-ethnicity data 
2
No patients were missing in the ‘other’ category  
      
5.4  Discussion 
 
 Three MICE methods and the missForest algorithm were compared against 
complete case analysis in MCAR, MAR and MNAR scenarios and several types of  
MNAR sensitivity analysis were then applied, both in a simulation and in an application 
to TBI data. One specific goal was to examine competing methods for approaching the 






Table 11: Traumatic brain injury (TBI) example: comparison of mortality odds ratio based on the 
updated race distribution against the odds ratios from complete case analysis, multiple imputation 
(MI), and MI with MNAR sensitivity analyses using the original TBI data, where approximately 
26% of the race-ethnicity data was missing. Under PMM-1 and selection model parameter 
weighting (“weighted”), shift parameters were iteratively adjusted to achieve the lowest relative 
bias when compared against the updated race distribution. Under pattern mixture model 2 (PMM-
2) shift parameters were iteratively adjusted in order to provide the closest match in the imputed 
data with the updated (“true”) race distribution. 
 




 Mortality OR by race-ethnicity group   
(95% CI) 
Ref group is NHW 
  NHB Hispanic Other 






















































































particular, this work examined whether MI methods that incorporate machine learning 
algorithms have any performance advantage, and whether any sensitivity analyses were 






 As expected, under MCAR and MAR conditions in the simulation, the MICE 
methods and miss Forest imputation provided reliable results with reasonably low bias 
and good efficiency when compared with complete case analysis. In particular, MICE 
with random forest imputation appeared to have a slight performance advantage, while 
the missForest method appeared to lag.   
 Under MNAR, where the scenario led to African American and Hispanic patients 
who died were more likely to have missing racial-ethnic group information, relative bias 
and coverage probabilities were extremely poor for those groups by all imputation 
methods.  In contrast, performance statistics were substantially better for imputed values 
for mean A1c and mean MPR. This difference may be due to the complex MNAR 
mechanism for the race groups, which also involved the outcome. It may also be due in 
part to the data structure: the two racial groups were small compared to the reference 
group, and there was thus less information available in the data for making effective 
imputations. For the mean A1c and mean MPR variables there was far more information 
available even with 50 percent of observations missing, and the imputation algorithms 
appeared to more effective.  
 The simulation demonstrated the challenges for applying MNAR sensitivity 
analysis, even in the unusual situation where the exact missingness mechanism was 
known. When the pattern mixture model was used to attempt to minimize the relative 
bias,  the imputed datasets contained unrealistic race-ethnicity distributions. Other 
sensitivity analyses were less successful. In particular, the selection model weighted-





outside the distribution for the MAR parameter estimates. Carpenter et al. discuss this 
limitation of the weighting method [36] . 
 Many of the conclusions drawn from the simulation were repeated with the TBI 
example. The multiple imputation methods produced relatively unbiased results for the 
non-Hispanic black group, for which missingness was generally MAR. On the other 
hand, in the Hispanic group, missingness was MNAR and biased results were seen as a 
result. In the TBI sensitivity analyses, though the pattern mixture model in which relative 
bias was minimized (PMM-1) appeared to be generally successful, the Hispanic group in 
the imputed results was 3.5 times larger than actual. In the pattern mixture model for 
which the goal was to match the true race distribution within the imputed data (PMM-2), 
biased results were still seen.  
 Further work to better understand the MNAR mechanisms that led to the missing 
race data could help inform future MNAR sensitivity analyses; however, there may be 
limits to how much can be achieved given the challenges seen in the simulation, where 









6.  Summary and Conclusions 
 
6.1 Summary  
 This work was motivated by two challenges that are commonly experienced by 
investigators who work with large VHA administrative healthcare datasets. These 
challenges included the need for better ways to account for the patient’s disease burden 
based on diagnostic codes, and the need for improved ways to handle missing data, 
particularly when the missingness exists in important covariates.   
 In the first manuscript, improved models for summarizing a patient’s disease 
burden were developed by applying seven machine learning and statistical methods. 
Each method provided more accurate predictions than models based on the Elixhauser 
index, and the pooled model, based on the combined predictions of the other six 
methods, usually had the best predictive performance.  
 In the second manuscript, an improved comorbidity summary score was 
developed based on the variable importance measures from the top performing models 
in the first manuscript. Three large VHA cohorts were used to both train these models 
and to validate the score. When compared against models based on the Elixhauser 





 In the third manuscript, four multiple imputation methods were compared using 
simulations and applications to real data under several types of missingness. The 
effectiveness of MNAR sensitivity analyses based on pattern mixture models and 
selection models was carefully examined, with implications for other VHA investigators 
who work with similar datasets. 
 
6.2  Discussion and Conclusions 
 The following paragraphs provide a summary of the insights and conclusions 
drawn from this research: 
 
6.2.1 Comparing machine learning to traditional statistical methods. 
 One goal in the first and third aims was to examine whether machine learning 
methods offered any advantages over traditional statistical approaches, particularly in 
their ability to automatically account for complex interactions and non-linear effects.  
 In the first aim, where the goal was to develop better ways to account for disease 
burden, predictive performance was compared between three machine learning and 
three statistical methods. The top performers (excluding the pooled model) included two 
machine learning methods (random forest and Bayesian additive regression trees) and 
one statistical method (elastic-net penalized logistic regression).  
 In the third aim, where several multiple imputation methods were compared, 
machine learning algorithms were incorporated in three models, while the fourth relied 





model with random forest incorporated within the multiple imputation with chained 
equations (MICE) framework, but MICE models using logistic regression and predictive 
mean matching often achieved similar results.  Random forest was far less successful as 
a stand-alone multiple imputation method, and neural net imputation within the MICE 
framework also performed poorly.  
 Overall, neither machine learning nor traditional statistical methods offered a 
clear advantage over the other group in these applications, and the investigator should 
carefully consider a wide variety of methods that are not limited to any particular type. 
 
6.2.2 Problems with modeling the correlation structure inherent in the ICD hierarchy. 
 One goal in the first aim was to take advantage of the hierarchy established by 
the ICD system, such that if data were sparse for a particular ICD code, information from 
similar codes within the same hierarchy could be used to approximate the effects for the 
sparse predictors. This approach was incorporated in the Probability Based Features 
models (dropped prior to completion of manuscript 1) and Modeled Averaged 
Regression Coefficients models. Both were among the weakest performing methods, 
and the original assumption is likely false that the correlation structure imposed by the 
ICD hierarchy can be used to make valid assumptions about sparsely populated ICD 
conditions. 
 
6.2.3 Performance advantages of ensemble models. 
 In the first aim, the model based on the pooled predictions of the other models 





ensemble of accurate and diverse classifiers is likely to perform better than the individual 
models. A somewhat different ensemble approach was used in the second aim, when 
the variable importance measures for the top three models applied to four populations 
were combined such those predictors with importance measures falling in the top 50% in 
all 12 results were selected for use in the summary score.  
 
6.2.4 New population insights based on variable importance models. 
 The variable importance results developed in the first and second aims 
demonstrated that a number of conditions not included in the Elixhauser index were 
highly predictive for five year mortality. As discussed in the second manuscript, 
Elixhauser developed the index in order to predict short-term events including in-hospital 
mortality, hospital charges, or length of stay, and she thus excluded a wide range of 
conditions from her index [2] since they were not associated with short-term events. It 
thus was not surprising to find a number of conditions associated with the patient’s 
functional status were strongly associated with longer-term outcomes such as five year 
mortality. These included Alzheimer’s disease, senile dementia, hearing loss, persistent 




6.2.5 Summary score weights based on statistical rather than clinical importance. 
 The variable importance results in the second aim highlighted that ICD codes for 





related to the codes’ primary use as billing mechanisms, such that codes for less serious 
conditions are often not recorded when the patient is critically ill since other conditions 
are more likely to be the main drivers of the patient’s medical costs. As a result, it would 
be possible to falsely conclude from ICD data that high blood pressure is protective 
against mortality [2]. Rather than exclude these associations, which are accurate from a 
statistical view, codes that predicted survival were instead included in summary score 
with a negative weighting, even when this appeared to contradict clinical evidence. As a 
result, many patients had an overall negative score, meaning more of their highly 
predictive ICD codes were associated with survival rather than mortality. Failure to take 
advantage of this artifact related to the ICD billing system would lead to substantially 
worse predictive performance. The disadvantage of such an approach is that the 
summary score does not provide a clinical picture of the patient’s comorbidities; instead, 
it provides a score used to predict mortality based on a comparison with millions of other 
Veterans for whether the patient has specific conditions that were most predictive in this 
population.   
 
6.2.6 Unbiased imputation of continuous variables under MNAR  
 In the third aim, MNAR scenarios were simulated for two continuous variables 
and for two of the four levels in a nominal categorical variable (race/ethnicity). None of 
the multiple imputation methods could provide unbiased results for the categorical 
variable, but several methods (random forest within MICE and logistic 
regression/predictive mean matching within MICE) provided unbiased results with 





values were missing. This difference may be due to the complex MNAR mechanism for 
the race groups, which also involved the outcome. It may also be due in part to the data 
structure: the two racial ethnic groups were small compared to the reference group, and 
there was thus less information available in the data for making effective imputations. 
For the mean A1c and mean MPR variables there was far more information available 
even with 50 percent of observations missing, and the algorithms were more effective. In 
summary, unbiased imputation under MNAR may be possible in some situations, but the 
investigator must be careful to conduct sensitivity analysis to try to verify the results are 
reasonable. 
 
6.2.7 Challenges for conducting sensitivity analyses under MNAR 
 Two types of sensitivity analysis were performed on imputed values in the third 
aim; these analyses were based on pattern mixture models and selection models (see 
section 2.3.9). In both the simulations and the application to real data, the MNAR 
mechanism was well understood. For the real data, this unusual situation existed 
because different sources of race/ethnicity information became available after the initial 
cohort had been formed, such that a more accurate variable with substantially lower 
missingness could be determined for comparison against the original. Thus, sensitivity 
analysis could be applied in situations where “true” parameter estimates existed. While 
the pattern mixture model approach could be used to produce reasonable inference, the 
imputed datasets under those conditions contained unrealistic race-ethnicity 
distributions. The selection model weighted-parameter method failed because the 





parameter estimates. While this work did not provide a solution for the MNAR 
race/ethnicity challenge likely faced by many investigators, it did provide important 
insights into the specific challenges researchers face when the reason for missingness is 
related to the missing data itself, or to other unknown variables. 
 
6.3 Limitations 
 Three Veteran populations were studied, with an average age of 73.7, and with 
an average of 4.2% women. Further work is needed to determine if the results from the 
first two aims could be generalized to a wider population. The results of the third aim 
involving missing data are less likely to be affected by the distinct populations.  
 While each aim considered a wide variety of available methods, these were 
limited to those which could be completed in a reasonable time on a typical desktop 
computer (64 bit machine with 16GB RAM, 2.56GHz processor) or on a shared server 
(64 bit server with 16GB RAM and a 2.36 GHz processor). While this limitation helped to 
ensure these methods can be directly applied by most investigators, additional methods 







6.4 Future Work 
Numerous areas for additional work were noted.  Since the original dissertation aims 
were developed to support specific research problems encountered in work with VHA 
administrative healthcare data, these future work goals are also well suited for 
application to VHA research.  
 1) In the second aim, the summary score algorithm involved a simple weighting 
scheme, and this was validated only on Veteran populations.  Additional work is planned 
in the following areas: 
  a. The score will be validated on other groups, including non-Veteran 
populations to help determine generalizability beyond the older, male population in which 
the score was originally developed. Other weighting schemes could boost predictive 
performance, and validation in other outcomes such as one-year mortality could widen 
its applicability. 
  b. The score’s definition will be expanded to include other types of 
administrative data, including vital signs, health services utilization, medications, and 
laboratory tests using a similar approach to that developed for the first two aims;  a wide 
variety of methods will be examined for each of the data types, and competing variable 
importance measures will be used to identify a group of variables with the strongest 
predictive performance.  This expanded score will be compared to existing measures, 
such as the Care Assessment Needs Score [80]. 
  c. Since the score is similar in some ways to a propensity score [81], 
applications for its use in adjusting for confounding and selection bias will be examined.  





score could be used to match patients by various exposures to attempt to control for  
selection bias or confounding. 
 2) Expanding further on the third aim, the following additional areas concerning 
multiple imputation merit further work: 
  a) Other multiple imputation methods could be applied to the missing 
race-ethnicity problem for comparison against the existing results.  For example, 
Gebregziabher and DeSantis [82] and Vermunt et al. [83] apply latent class models 
within the multiple imputation framework.  Such models are typically limited to only 
categorical data, and it would be difficult to apply them directly to most administrative 
healthcare datasets.   However, LCMI may still be a useful tool for investigating the 
missing race-ethnicity problem. 
  b)   Bayesian Additive Regression Trees (BART)  could be tested as the 
imputation method within the MICE framework within a parallel computing environment. 
While this method was successfully implemented in the third aim, it was too slow in a 
single-processor environment to be feasible.  
 3)  The MNAR sensitivity analyses conducted as part of the third aim were limited 
to missing race-ethnicity, and thus involved only a multi-level, nominal categorical 
variable.  This work will be expanded to include all variable types and a wider range of 
methods in order to better understand the limitations of current work in this area, and to 
look for areas where methodological development is warranted.  The following 
paragraphs provide an expanded summary of possible approaches when MNAR 





  a)  The first approach involves developing a joint model that attempts to 
incorporate the MNAR mechanism.  Such a joint distribution may be very complex and 
inference may require MCMC methods.  As Molenberghs and Lesaffre discuss [33], 
such models are based on untestable assumptions, and may be very sensitive to minor 
changes in such assumptions. For these reasons sensitivity analyses based on models 
developed from an MAR basis are more commonly seen. 
  b) Another option is to consider the addition of auxiliary variables, which 
may help to explain why missingness occurred, but are otherwise not useful for 
explaining the outcome.  Raykov et al. describe that such variables could be included in 
the maximum likelihood or multiple imputation models, and could perhaps help the 
models meet the underlying MAR assumption [84].  However this approach, like the 
basic MNAR models in paragraph (1), may still rely on untestable assumptions, and it 
may not be possible to identify the correct auxiliary variables to produce the needed 
improvement. 
  c)  The most common approach is to conduct sensitivity analyses on 
MAR models to test whether the inference from models is sensitive to the imposed 
changes.  The analyst must select what types of analyses to conduct based on a “best 
guess” for what caused the missingness.   As discussed in the third aim, most sensitivity 
analyses are broadly grouped into selection model or pattern mixture model approaches 
[32, 85]. The data type will further dictate how the analyses are conducted. 
   i) Sensitivity analyses based on pattern mixture models typically 
involve one or more shift parameters.  For continuous variables, scale factors and shift 





parameters are applied within the appropriate generalized linear model; for example, in 
logistic regression, the shift represents the change in the log-odds that a specific level of 
the variable is observed. Different shifts could be imposed for each level of the variable 
[86]. 
   ii) Selection model sensitivity analyses can take numerous forms; 
one method was examined in the third aim [36].  Another approach involves developing 
a measure of local influence.  Here the goal is to produce an index that quantifies how 
much an MAR model deviates from its MLE when it is perturbed towards an MNAR 
condition.  Verbeke et al. [30] derived this approach for normally-distributed longitudinal 
data, and Troxel et al. demonstrated a similar method for generalized linear models [87].   
While Verbeke’s approach examines the model’s behavior at the individual level, Troxel 
is concerned with behavior at the group level. Troxel’s Index of Sensitivity to non-
ignorability (ISNI) is easily implemented since it relies only on determining the MLE from 
complete case data, and a separate model for predicting missingness. 
  d) Summary and description of future work: while much work is available 
in the literature concerning the development of MNAR models (paragraphs a and b 
above), there is a strong consensus that this effort is less likely to be successful because 
the basic assumptions for such models are untestable.  Sensitivity analyses continue to 
offer the most promise, and my work will focus on two areas: 
   i) Pattern mixture model adjustments for other variable types 
besides nominal categorical data, particularly continuous variables. 















This Appendix provides a description of the software program files that were developed 
to support this research. These files and supporting sample datasets are available in 
GitHub (user: rcccward, respository: comorbidity-models). All R functions described in 
this appendix were developed using R version 3.2.3 [88].  SAS macros were developed 
using SAS software (SAS Institute Inc., Cary, NC), version 9.4. 
 
A.2 Comorbidity models development (first manuscript) 
A.2.1  Description (models_func) 
 This R function (models_func) applies the top-performing methods applied in the 
first aim to summarize disease burden from ICD-9-CM data by training and validating 
models and comparing each method’s predictive performance with models based on the 
Elixhauser index using AUC, sensitivity, specificity, positive predictive value (PPV), 
negative predictive value (NPV), and net reclassification improvement statistics for 





model, random forest, Bayesian additive regression trees, and an ensemble model 
based on the pooled predictions of the other models.  
 
A.2.2  Usage (models_func) 
models_func(patient_dat, binary_dat, elixmat, iterations, size, covariate_flag) 
 
A.2.3  Arguments (models_func) 
patient_dat Dataframe containing the outcome and covariates such as race, 
age, gender, marital status, and clinical variables. Categorical 
variables should be stored as factors 
binary_dat Dataframe containing binary ICD-9 data, one row per patient and 
one column per unique ICD-9 code. Variables should be stored as 
factors. The column names should list each 5 digit code. 
elixmat Dataframe containing the Elixhauser-Quan comorbidities, one row 
per patient, and one binary column for each of the 31 
comorbidities, stored as factors. Alternatively, the user could 
establish a different comparison comorbidity measure in place of 
the Elixhauser index, where each column serves as an 
independent predictor in the comparison model. 
iterations The number of bootstrapped training and validation samples to be 
generated in order to determine the distribution of the comparison 
statistics. 





covar_flag A flag indicating whether patient covariates from patient_dat 
should be included in the models, or whether inference should be 
based solely on ICD-9 information. 
 
A.2.4  Output objects (models_func) 
A single list is returned containing the following objects: 
meanvarimpRF A vector of the random forest ICD-9 variable importance 
measures, with one measure for each column of binary_mat. 
meanvarimpBART A vector of the Bayesian additive regression trees ICD-9 variable 
importance measures, with one measure for each column of 
binary_mat. 
meanvarimpREG A vector of the elastic-net regression ICD-9 variable importance 
measures, with one measure for each column of binary_mat. 
output A matrix containing the performance statistics and their 95% 
confidence limits for models based on the Elixhauser index, 
random forest, BART, elastic-net, and the pooled model. Statistics 
include AUC, sensitivity, specificity, Brier score, net 
reclassification error (NRI) for events and non-events. 
train_id, test_id Indices of training and validation observations used in partitioning 
the dataset such that the same partition is used during summary 







A.2.5  Examples (models_func) 
Sample datasets patient_dat, binary_dat, and elixmat are provided with the program 
code in GitHub. These are simulated observations for a diabetes patient population 
similar to the Veteran population studied in aims 1 – 3.  The following console summary 
is provided in addition to the information stored in the returned object: 
 
pred_out<-models_func(dat,binary, elixmat,iterations, size, covar_flag) 
Model Performance Comparison (covariates not included in model) 
1000  iterations 
size =  2000 patients 
                 Elix     RF       BART    REG      Pool   
AUC-UCL          0.709    0.834    0.841   0.840    0.854 
AUC              0.684    0.820    0.823   0.823    0.837 
AUC-LCL          0.663    0.799    0.806   0.803    0.819 
 
sens-UCL         0.537    0.702    0.748   0.709    0.733 
sens             0.485    0.672    0.719   0.663    0.701 
sens-LCL         0.424    0.627    0.680   0.609    0.660 
 
spec-UCL         0.813    0.841    0.802   0.842    0.834 
spec             0.772    0.818    0.774   0.820    0.810 
spec-LCL         0.731    0.788    0.739   0.794    0.785 
 
Brier-UCL        0.228    0.182    0.178   0.180    0.173 
Brier            0.222    0.172    0.171   0.171    0.164 
Brier-LCL        0.215    0.164    0.161   0.162    0.155 
 
NRIevent-UCL     -----    0.246    0.280   0.225    0.273 
NRIevent         -----    0.188    0.234   0.178    0.217 
NRIevent-LCL     -----    0.142    0.189   0.119    0.169 
 
NRInonevent-UCL  -----    0.088    0.041   0.095    0.079 
NRInonevent      -----    0.045    0.002   0.048    0.038 






A.3  Summary score development (second manuscript) 
A.3.1  Description (score_fn) 
 This function demonstrates the method used in the second aim to develop a 
summary score based on variable importance measures from the top performing models 
in aim 1. Those ICD-9 codes with importance measures in the top 50% among all 
models were included in the summary score, and codes associated with mortality and 
survival were assigned weights of +1 or -1, respectively. The patient’s score is a simple 
weighted sum of how many of the selected ICD-9 codes were found in the patient’s 
record. Score performance was compared to models based on the Elixhauser-Quan 
index using AUC, sensitivity, specificity, Brier Index, and net reclassification index 
statistics. Note that the models function (models_func) described above must be run first 
since score_fn requires variable importance rankings from models_func in order to 
develop the summary score. 
 
A.3.2  Usage (score_fn) 
Score_fn(models_out, patient_dat, binary_dat, elixmat, iterations, size, covar_flag) 
 
A.3.3  Arguments (score_fn) 
models_out  This is the list object produced by models_func, above. 
patient_dat Dataframe containing the outcome and covariates such as race, 
age, gender, marital status, and clinical variables. Categorical 





binary_dat Dataframe containing binary ICD-9 data, one row per patient and 
one column per unique ICD-9 code. Variables should be stored as 
factors. The column names should list each 5 digit code. 
elixmat Dataframe containing the Elixhauser-Quan comorbidities, one row 
per patient, and one binary column for each of the 31 
comorbidities, stored as factors. Alternatively, the user could 
establish a different comparison comorbidity measure in place of 
the Elixhauser index, where each column serves as an 
independent predictor in the comparison model. 
iterations The number of bootstrapped training and validation samples to be 
generated in order to determine the distribution of the comparison 
statistics. 
size The number of observations within each bootstrapped sample. 
covar_flag A flag indicating whether patient covariates from patient_dat 
should be included in the models, or whether inference should be 
based solely on ICD-9 information. 
 
A.3.4  Output objects (score_fn) 
Score_fn produces a list with the following objects: 
comorbidities This is a list of the ICD-9 codes from binary_mat which were 
included in the summary score. 
weights This is the weights (+1 for mortality, -1 for survival) assigned to 





output Matrix of performance statistics and 95% confidence limits for the 
model based on the Elixhauser-Quan index and the summary 
score.  
 
A.3.5  Examples (score_fn) 
Console output: 
>score_run<-score_fn(pred_out,dat,binary, elixmat, iterations,size,  
           covar_flag) 
Score performance (covariates not included in model) 
1000  iterations 
                 Elix     Summary Score 
AUC-UCL          0.693    0.827 
AUC              0.676    0.816 
AUC-LCL          0.663    0.806 
 
sens-UCL         0.512    0.719 
sens             0.472    0.700 
sens-LCL         0.436    0.681 
 
spec-UCL         0.795    0.796 
spec             0.773    0.781 
spec-LCL         0.744    0.765 
 
Brier-UCL        0.228    0.179 
Brier            0.224    0.174 
Brier-LCL        0.219    0.169 
 
NRIevent-UCL     -----    0.265 
NRIevent         -----    0.228 
NRIevent-LCL     -----    0.184 
 
NRInonevent-UCL  -----    0.038 
NRInonevent      -----    0.008 





A.4 Missing data analyses simulation (third aim) 
A.4.1  Description (missdat_sim) 
This function compares compares several machine learning and model-based multiple 
imputation methods for dealing with missing covariate data under missing completely at 
random (MCAR), missing at random (MAR) and missing not at random (MNAR) 
scenarios. Beginning with complete case data, the function simulates the desired 
missingness scenario, and imputation performance is evaluated using relative bias, root 
mean squared error, efficiency and coverage probability statistics.  
 
A.4.2  Usage (missdat_sim) 
Missdat_sim(patient_dat, MissType, pctMiss, size, iterations) 
 
A.4.3  Arguments (missdat_sim) 
patient_dat Dataframe containing the outcome and covariates such as race, 
age, gender, marital status, and clinical variables. Categorical 
variables should be stored as factors.  
MissType  The missingness pattern to be simulated in patient_dat. The 
options are “MCAR”, “MAR”, “MNAR”. See details (below) for 
further information concerning the missingness scenarios. 
pctMiss The fraction of patients in the bootstrapped dataset with any 





iterations The number of bootstrapped training and validation samples to be 
generated in order to determine the distribution of the comparison 
statistics. 
size The number of observations within each bootstrapped sample. 
 
A.4.4  Details (missdat_sim) 
In the example dataset, under MCAR, missingness is generated for race, mean_mpr and 
mean_A1c variables completely at random. Under MAR, the probability of missing race 
is higher when the patient died, the probability of missing mean_mpr is higher when the 
patient is not married, and the probability of missing mean_A1c is greater when the 
patient lives in a rural area. Under MNAR, missing race is more likely when the patient is 
non-Hispanic black or Hispanic and died; missing mean_mpr is more likely when the 
patient’s medication possession ratio (MPR) is above the median value among all 
patients; missing mean_A1c is more likely when the patient’s mean A1c level is above 
the median value for all patients.  
 
 
A.4.5  Output objects (missdat_sim) 
missdat_sim returns the following objects within a single list: 
output This is a list of dataframes, one per multiple imputation method. Each 
provides the performance statistics with 95% confidence limits for that 






prob.miss This provides a list of matrices, one per iteration, that summarizes the 
missingness probabilities under each scenario. This permits the user to 
verify that the requested scenario was generated. 
odd.miss This provides a list of matrices, one per iteration, that summarizes the 
missingness odds ratios for each scenario. Odds ratios are generated 
from separate logistic models for each variable with missing values, 
where the outcome is a missingness indicator. This permits the user to 
verify that the requested scenario was generated.  
 
A.4.6  Example (missdat_sim) 









                 missType pctMiss MIType   intercept     single1     rural1 
rel.bias-median         3       2      1 -0.08798639 -0.01950551  0.2395583 
rel.bias-UCL            3       2      1  0.14671663  0.91969042  3.3358113 
rel.bias-LCL            3       2      1 -0.34776225 -1.28024266 -1.5368577 
ratio_var-median        3       2      1 43.06712909 43.30529920 41.1828111 
ratio_var-UCL           3       2      1 46.45898708 46.09625178 42.1956729 
ratio_var-LCL           3       2      1  3.00000000  2.00000000  1.0000000 
rmse-median             3       2      1  1.67613116  0.31493434  0.2080584 
rmse-UCL                3       2      1  2.71125326  0.40489587  0.3515986 
rmse-LCL                3       2      1  3.00000000  2.00000000  1.0000000 
CovProb-pct             3       2      1  1.00000000  0.66666667  0.6666667 
                      male1         age      race2       race3      race4 
rel.bias-median   0.1954343 -0.05470550 -14.729965  -6.3138931 -0.1648961 
rel.bias-UCL      0.4009245  0.23325525 -10.182891  -4.6691325 -0.1515784 
rel.bias-LCL     -1.4137884 -0.12348141 -16.919479  -7.7017439 -0.2718389 
ratio_var-median 39.0422326 41.81670229 199.818772 156.8015798 45.6921451 
ratio_var-UCL    44.2419931 44.26315920 434.076280 484.9759815 59.3085076 
ratio_var-LCL    -0.3477623 -1.28024266  -1.536858  -1.4137884 -0.1234814 
rmse-median       0.6738387  0.01871629   2.659716   2.1834179  0.3735142 
rmse-UCL          0.8181008  0.02679147   3.095889   2.7849435  0.4686748 
rmse-LCL          3.0000000  2.00000000   1.000000  -0.3477623 -1.2802427 







                     meana1c     meanmpr 
rel.bias-median   -1.1485749 -0.06151144 
rel.bias-UCL      -0.6711596  0.07616864 
rel.bias-LCL      -1.2526204 -0.17614600 
ratio_var-median  53.8702350 52.63004672 
ratio_var-UCL     65.4548691 55.82645845 
ratio_var-LCL    -16.9194787 -7.70174393 
rmse-median        0.1643232  0.44817799 
rmse-UCL           0.1722005  0.63815386 
rmse-LCL          -1.5368577 -1.41378845 
CovProb-pct        0.6666667  1.00000000 
 
 
A.5 Sensitivity analyses: selection model 
A.5.1  Description 
This simulation program written in R implements the method described by Carpenter et 
al. for selection model sensitivity analysis after multiple imputation under MAR [36]. The 
program in its current form requires the use of the example dataset, patient_dat, which is 
stored with the program on GitHub.  
A.5.2  Usage  
Given the example dataset, a separate function is used to generate MNAR missingness 
in the race/ethnicity variable in which race is more likely to be missing in non-Hispanic 
blacks and Hispanics who died. These data are then imputed under MAR assumptions 
using MICE with logistic regression imputation [26]. Next, the weighted sensitivity 
approach is applied through an iterative process to examine candidate values for the 
delta vector, which adjusts how strongly a given level of the race variable is associated 
with the logodds that it is missing [36]. The user then selects the best values for delta 









The following arguments must be provided: 
patient_dat Dataframe containing the outcome and covariates such as race, 
age, gender, marital status, and clinical variables. Categorical 
variables should be stored as factors.  
MissType  Must be set to “MNAR” for the purposes of the sensitivity analysis.   
pctMiss The fraction of patients in the bootstrapped dataset with any 
missing value. Options are restricted to 0.1, 0.3, and 0.5. Default 
value is 0.3. 
delta Elements of this vector adjust how strongly a given level of the 
race variable is associated with the logodds that it is missing. The 
user could optionally adjust the coded values that are iteratively 
tested.  
 
A.5.4  Output objects  
Output  An output matrix provides a summary of results for each 
combination of delta values. These include the estimated race 
coefficients under MNAR, with relative bias, efficiency, root mean 
squared error and coverage probability provided for each. Finally, 






Weights This is a list, with a separate matrix for each iteration, providing 
the calculated weights. See Carpenter et al. [36]for further 
information on the weights. 
 
A.6 Sensitivity analyses: pattern mixture model 
A.6.1  Description 
This SAS program demonstrates the method for adjusting each level of the imputed 
race/ethnicity variables using pattern mixture models [32].  For now, it requires the use 
of the provided example dataset. 
 
A.6.2  Usage 
The demonstration includes three macros which work together: 
%macro missgen  This macro generates MNAR missingness for the race 
variable in the provided SAS dataset (simdat). See 
sections A.4 and A.5 for more information on the MNAR 
association. The macro requires a separately provided 
SAS program file (missgen.sas) be available. The user 
should modify the first line of the macro to indicate where 
this file is stored. The SAS dataset simdat must be loaded 
in the user’s SAS work directory. 
%macro tune This macro uses SAS PROC MI to perform multiple 
imputations with pattern mixture model adjustments. Four 





are the adjustments to each of the race/ethnicity variables. 
PROC GENMOD and PROC MIANALYZE are then used 
to analyze and combine the multiple imputation results. 
%macro shell This macro helps the user to iteratively determine the best 
combination of the four race/ethnicity adjustment 
parameters. For the range of selected values and for the 
total number of desired iterations, each combination of 
adjustments is tested using the %missgen and %tune 
macros.  
 
A.6.4  Output objects  
The results of %shell are stored in two files found in the work directory: 
results_freq  This table provides the race distribution for each imputed 
dataset after MNAR adjustment. 
results_OR This table provides the results for each combination of the 
adjustment parameters. Provided results include 
parameter estimates and their standard errors, the 
mortality odds ratio and 95% confidence limits, relative 
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